Malaria perception among pregnant women in Chhattisgarh, India by Bondzie, Philip A.
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2019
Malaria perception among
pregnant women in Chhattisgarh,
India
https://hdl.handle.net/2144/34837
Boston University
   
BOSTON UNIVERSITY 
 
SCHOOL OF MEDICINE 
 
 
 
 
 
Thesis 
 
 
 
 
 
MALARIA PERCEPTION AMONG PREGNANT WOMEN IN 
CHHATTISGARH, INDIA 
 
 
by 
 
 
 
 
PHILIP APRAKU BONDZIE 
 
Ph.D., Boston University School of Medicine, 2014 
B.Sc. Kwame Nkrumah University of Science and Technology, Kumasi, Ghana 2007 
 
 
 
 
 
Submitted in partial fulfillment of the 
 
requirements for the degree of 
 
Master of Science 
 
2019 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2019 by 
 PHILIP APRAKU BONDZIE 
 All rights reserved  
   
Approved by 
 
 
 
 
First Reader   
 Lora Sabin, M.A., Ph.D. 
 Associate Professor of Global Health 
 
 
Second Reader   
 Mary L. Warner, M.MS.c, PA-C 
 Assistant Professor of Medicine 
 
 
 
  iv 
ACKNOWLEDGMENTS 
 
Foremost, I would like to thank my thesis advisor, Dr. Lora Sabin for her tremendous 
support, expertise, enthusiasm, optimism and time as I wrote my thesis. I would also like 
to thank the staff of the Physician assistant program for all the support they offered me.     
I would finally want to thank my wife, Attorney Deborah Apraku Bondzie, my son 
Emmanuel and daughter Elise Bondzie, family, and friends for their unwavering love, 
support and for believing in me. 
 
  
  v 
MALARIA PERCEPTION AMONG PREGNANT WOMEN IN 
CHHATTISGARH, INDIA 
PHILIP APRAKU BONDZIE 
ABSTRACT 
 Background: Malaria in pregnant women continues to be a public health problem 
in India. The prevalence of malaria in pregnancy is particularly high in the tribal conflict 
areas of India such as Chhattisgarh. Pregnant women have less acquired immunity 
protecting them against malaria than non-pregnant women of child bearing age. The 
decreased immunity results in a much more severe presentation of malaria symptoms, 
and potential death of both mother and fetus during malaria in pregnancy. Recognizing 
the need for effective malaria interventions in pregnant women, global and national 
malaria prevention and treatment guidelines have been established. Practice of these 
guidelines has been found to be inadequate in the Asian Pacific Region.  
Literature review findings: Qualitative studies on the knowledge, attitudes and 
practices of malaria interventions have demonstrated that meeting communities at their 
level of understanding is essential in circumventing malaria spread. In an effort to create 
a synergy between health care workers, national and global malaria control strategies and 
pregnant women, there is the need to identify pregnant women’s knowledge, attitudes and 
practices of malaria interventions. Currently, there is no data on the knowledge, attitudes 
and practices of pregnant women in the conflict districts of Chhattisgarh, India, where 
malaria prevalence and related symptoms have been identified to be significantly high.  
  vi 
Proposed project: This study seeks to assess the knowledge, attitudes and 
practices of malaria prevention and treatment in pregnant women in the conflict areas of 
Chhattisgarh, India, using a cross-sectional qualitative research design. This study will 
highlight the understanding of malaria transmission, perceptions of cause, recognition of 
signs and symptoms, treatment-seeking behaviors, preventive measures and practices of 
pregnant women who visit the antenatal clinic and those who do not. 
Conclusion: If this study demonstrates knowledge and attitudes that favor 
customary or unproven methods of malaria interventions as shown in previous studies, 
then this may explain the present rate of MIP in these districts and hence the need for 
specific mediations for controlling and preventing malaria in this populace. 
Significance: Findings from this study will help inform malaria education 
programs, health policies and practices that are tailored or targeted towards pregnant 
women in Chhattisgarh, India.  
  vii 
TABLE OF CONTENTS 
 
TITLE……………………………………………………………………………………...i 
COPYRIGHT PAGE……………………………………………………………………...ii 
READER APPROVAL PAGE…………………………………………………………..iii 
ACKNOWLEDGMENTS ................................................................................................. iv 
ABSTRACT ........................................................................................................................ v 
TABLE OF CONTENTS .................................................................................................. vii 
LIST OF ABBREVIATIONS ............................................................................................ ix 
INTRODUCTION .............................................................................................................. 1 
Background ..................................................................................................................... 1 
Statement of the Problem ................................................................................................ 3 
Hypothesis....................................................................................................................... 4 
Objectives and specific aims ........................................................................................... 4 
REVIEW OF THE LITERATURE .................................................................................... 6 
Overview ......................................................................................................................... 6 
Existing research ........................................................................................................... 22 
METHODS ....................................................................................................................... 31 
Study design .................................................................................................................. 31 
Study population and sampling ..................................................................................... 31 
  viii 
Data collection .............................................................................................................. 32 
Data analysis ................................................................................................................. 33 
Timeline and resources ................................................................................................. 33 
Institutional Review Board ........................................................................................... 33 
CONCLUSION ................................................................................................................. 34 
Discussion ..................................................................................................................... 34 
Summary ....................................................................................................................... 36 
Clinical and/or public health significance ..................................................................... 37 
APPENDIX 1 .................................................................................................................... 38 
LIST OF JOURNAL ABBREVIATIONS........................................................................ 44 
REFERENCES ................................................................................................................. 46 
CURRICULUM VITAE ................................................................................................... 73 
 
  
  ix 
LIST OF ABBREVIATIONS 
 
ANC ............................................................................................................. Antenatal clinic 
APR ......................................................................................................Asian Pacific Region 
IPTp............................................................. Intermittent preventive treatment in pregnancy 
IRS ............................................................................................... Indoor Residual Spraying 
ITN ....................................................................................................Insecticide-treated nets 
KAP................................................................................ Knowledge, attitudes and practices 
LLIN ...................................................................................... Long-lasting insecticidal nets 
MC ................................................................................................................... Mobile clinic 
MIP ..................................................................................................... Malaria in pregnancy 
WHO .......................................................................................... World Health Organization 
 
 
 
 
 1 
INTRODUCTION 
Background 
Despite a decline in global cases from 262 million in 2000 to 214 million in 2015, 
malaria continues to cause more deaths worldwide than any other parasitic disease. In the 
Asia Pacific Region (APR), India is home to 75% of all malaria cases and deaths1. India 
alone recorded 1 million to 1.3 million malaria cases each year from 2010 to 2014, with 
95% of the country’s population at risk of infection2. True numbers are thought to be even 
higher than those reported, due to ineffective surveillance systems, inadequate diagnostic 
testing, and patients not seeking treatment 3–5. Malaria poses an enormous financial 
burden of US$ 1940 million annually in India mostly stemming from lost earnings6. 
However, India represents one of the countries in the world still with limited malaria 
investment7. India’s slow pace in preventing malaria may result in a potential 
challenge to eliminating malaria worldwide8. 
An estimated 91% of India’s documented malaria cases are found in people living 
in tribal and rural areas, as well as in urban dwellers with poor sanitary and housing 
conditions. Children and pregnant women in these populations face the most risk9–12 
associated with adverse outcomes such as maternal anemia, preterm labor, still births and 
low birth weight13–18. Studies have shown that pregnant women have a three-fold increased 
risk of malaria infection compared to non-pregnant women who harbor lower levels of the 
disease causing parasite19–22. In the APR, pregnant women are also found to have less 
acquired immunity against malaria than pregnant women in Africa23,24. As a result, 
pregnant women with malaria in the APR experience more severe presentations of malaria 
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symptoms25. It stands to reason that pregnant women with malaria in the APR have an 
increased potential for maternal and fetal death compared to their African counterparts. 
To prevent malaria morbidity and mortality in pregnant women and their babies, 
several guidelines and preventive measures have been put in place worldwide 26–28. These 
guidelines and preventive measures are successfully being implemented in Africa but their 
application in the APR is confounded by several factors29,30. For example, although basic 
preventive measures such as indoor residual spray (IRS) and bed nets are effective and 
inexpensive, only about 20% of the at-risk Indian population uses them31. 
To gain a better understanding of the views and practices of pregnant women 
regarding malaria, several qualitative studies assessing the knowledge, attitudes and 
practices (KAP) of this population in Africa have been studied32–35. These studies have 
provided insight into interventions that are being utilized by various communities and 
subjects, as well as the factors that motivate a community's decision to implement specific 
malaria prevention methods32,36,37. Other studies have shown that interventions that target 
communities through education have significantly improved KAP over time, which has 
decreased disease burden38,39. Minimal qualitative studies on this topic have however been 
conducted in some states in India40–42. Given the prevalence of malaria in India and the 
adverse implications of the disease in pregnant women, it is imperative that further 
qualitative research is conducted in this malaria endemic country. 
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Statement of the Problem 
Malaria continues to pose a significant threat in India. On top of other malaria-
related challenges, forested tribal areas of India such as Chhattisgarh, Andhra Pradesh and 
Telangana, have had ongoing conflicts, significantly jeopardizing their healthcare43.  
Despite the establishment of mobile clinics and regular malaria preventive activities 
in the above conflict regions, there is persistent malaria transmission, especially in pregnant 
women. Data from mobile clinics established in these states showed that in a population of 
575 pregnant women, 30% had malaria, with 21% of those diagnosed asymptomatic44. 
Malaria remains endemic in Chhattisgarh, particularly in the southern districts of 
the state where insurgency persists. In 2016, Chhattisgarh reported the second highest 
number of malaria cases among Indian states45. A draft report of community-based 
monitoring in Chhattisgarh for 2012 to 2013 identified malaria as the most common cause 
of death in the state46. In another study, estimates of malaria in pregnancy cases were as 
high as 220,000 per year, with an estimated 95,000 still births and miscarriages, and a 
thousand maternal births yearly47. Malaria continues to pose a significant threat to pregnant 
women and their babies in Chhattisgarh. In a recent study performed in Chhattisgarh, 
eighteen percent of children previously born to malaria-infected women died in their first 
year44.  
It is unclear why the high rates of malaria persist. The ongoing transmission of 
malaria could be associated with inadequate knowledge, and poor attitudes and practices 
relating to malaria prevention and treatment. A recent qualitative study performed in the 
Jharkhand state, a malaria endemic region in India, demonstrated poor understanding of 
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malaria transmission and utilization of effective malaria prevention methods among 
pregnant women40. In that study, pregnant women expressed concerns about the cost and 
side effects of drugs as limitations to utilizing malaria interventions. Practices such as the 
use of traditional remedies (69%) or untreated bed nets (89%) were not uncommon. At this 
time, nothing is known about the KAP of pregnant women towards malaria interventions 
in the conflict areas of Chhattisgarh state. Cases of malaria in pregnancy remain quite high 
there, additionally, with adverse effects on pregnant mothers and babies. 
  Identifying the knowledge and perceptions pregnant women have regarding malaria 
risk, preventive methods, traditional healers versus modern healthcare providers, drug cost, 
drug safety and drug availability will help inform policy makers on the factors influencing 
malaria prevention and treatment. It will also help them devise potential ways of improving 
these measures for the Chhattisgarh population. 
Hypothesis 
Levels of malaria knowledge vary among pregnant women in Chhattisgarh, with 
many displaying knowledge and practices that are influenced by both modern methods and 
belief in traditional practices.   
Objectives and specific aims 
Substantial research has been done on the African continent to assess individual 
and community perceptions of malaria interventions. Results from such research have 
impacted policies and practices of communities, as well as how health care workers 
operate. The main objective of this study is to assess the knowledge, attitudes and practices 
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of pregnant women in relation to malaria prevention in the conflict areas of Chhattisgarh 
state, India. 
The specific aims include 
1. To describe or identify the local perceptions of malaria prevention and treatment 
among pregnant women;  
2. To identify the factors that hinder or promote effective malaria prevention and 
treatment in pregnancy; 
3. To examine the relationship between knowledge and practice of pregnant women 
who visit the antenatal clinic (ANC) compared with those who do not visit the 
ANC.
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REVIEW OF THE LITERATURE 
Overview 
Malaria Burden 
Malaria continues to pose a public health problem worldwide. More than half of 
the world’s population is at risk of malaria, with children under 5 facing the greatest 
threat48. In 2016, governments of malaria endemic countries and international agencies 
spent almost US$ 2.7 billion in malaria control and prevention methods. However, this 
investment was less than half the amount needed to eliminate 40% of malaria cases and 
deaths worldwide 49.  
But there are some hopeful signs. Malaria cases declined 14% from 2010 to 2015, 
down to 212 million infections (95% CI: 192–257 million)50. Deaths also fell 22% in the 
same period50. Of the 91 countries assessed by the WHO, India and 14 Sub-Saharan 
countries contributed to 80% of the global malaria burden. Despite the overall decline in 
malaria cases, the APR has seen a marginal increase in case incidence49. 
Over the years, decreased malaria mortality (particularly in children under 5) 
resulted in an increased life expectancy at birth of 1.2 years in the WHO African Region. 
This trend accounted for nearly 20% increase in total life expectancy, from 50.6 years in 
2000 to 60 years in 2015 (a gain of 9.4 years)50. Between 2000 and 2015, 17 countries 
successfully eliminated malaria. About 70% of malaria cases averted were due to 
successful implementation of malaria control efforts50. This outcome shows the need and 
possibility of eradicating malaria in malaria endemic countries. 
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Malaria Parasite and Immunity 
The word malaria, previously associated with marshy areas, comes from Italian for 
“bad air”. In the latter years of the 19th century, Ronald Ross, the first British Nobel 
Laureate, discovered that malaria was transmitted by mosquitoes. Later, Giovanni Battista 
Grassi showed that the female Anopheles mosquito acted as the vector for the parasite 
causing malaria. Today, scientists and health professionals know that the malaria parasite 
can also be transmitted by infected blood transfusion or through vertical transmission. 
There are more than 100 species of Plasmodium that cause malaria. Among them, six 
identified Plasmodium species infect humans. These species include: Plasmodium 
falciparum, Plasmodium vivax, Plasmodium ovale curtis, Plasmodium ovale wallikeri, 
Plasmodium malariae and Plasmodium knowlesi51. Each Plasmodium species varies in 
morphology, geographical locations, impact on the human immune system and response to 
drugs. Adequate knowledge and understanding of the species differences are required to 
direct effective malaria prevention, diagnosis and treatment. 
Individuals with repeated malaria infections acquire some level of immunity52–55. Upon 
reinfection, these immune individuals exhibit decreased levels of parasitemia and severity of 
symptom presentation56,57. This acquired immunity is transient and diminishes when there is no 
continuous exposure to the malaria parasite56. Infants <6 months old are protected from malaria 
due to transferred maternal antibodies and the presence of fetal hemoglobin58. This phenomenon of 
modified acquired immunity is recognized in sub-Saharan Africa59. In low endemic regions, such 
as Latin America and Asia, age and patient immune status play little role in malaria parasite 
incubation time and onset of symptoms59. The risk of severe malaria disease is thus higher in Asians 
and Caucasians compared to Blacks60 
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Malaria Biology 
An understanding of malaria biology is instrumental in developing needed tools for 
malaria prevention, control and treatment. Knowledge on the part of the community will 
help ensure adherence to any policies, management methods or treatments available for 
eliminating malaria. 
As stated above, malaria is caused by malaria parasites. Within infected humans, 
malaria parasites flow through the bloodstream as motile sporozites. The sporozites seek 
out and invade liver cells, an important step for the life cycle of the parasite61 . Within the 
liver cells, the sporozites undergo asexual reproduction, known as exo-erythrocytic 
schizogony, with each sporozite producing tens of thousands of daughter merozoites. The 
merozites alter the liver cell to ensure safe exit into the bloodstream62. Upon exit into the 
bloodstream, the merozoites enter the erythrocytes within which schizogony occurs63. 
Matured merozoites (trophozoites and schizonts) then exit the erythrocytes, causing 
destruction of the red blood cells. The merozoites then infect other RBCs, continuing the 
asexual blood stage life cycle. 
For every cycle, the parasite multiplies 6-20 times64. Clinically, malaria parasites 
can be detected once they reach high numbers in the bloodstream (>100 million parasites) 
using standard diagnostic tools. 
Clinical features 
Malaria symptoms are associated with other diseases, as well as with pregnancy. It 
is important for individuals and communities to be knowledgeable about these symptoms 
so they can seek early medical care. The at-risk population, particularly infants and 
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pregnant mothers, stand to benefit most from being able to identify potential symptoms 
and present to the healthcare center for further care. 
Malaria symptoms can be classified into two groups, uncomplicated malaria and 
severe malaria. After infection, a patient may recover, remain asymptomatic with 
parasitemia, progress to uncomplicated disease, or further progress to severe malaria and 
(if not treated) death. 
Uncomplicated Malaria 
Most symptoms associated with uncomplicated malaria are non-specific. These 
symptoms are either gradual or fulminant across all the Plasmodium species. The 
symptoms may present early or late in the disease process. Initial symptoms include flu-
like symptoms such as headache, arthralgia, myalgia, shivering, diaphoresis, abdominal 
discomfort and fatigue59. Other symptoms include dizziness, lassitude, anorexia, and 
chills65. This is sometimes followed by nausea, convulsions, watery diarrhea and 
orthostatic hypertension. The cardinal presentation of malaria is fever. Among the different 
Plasmodium species, febrile conditions tend to be most prevalent in P. falciparum 
infections. Using in vitro conditions, it is hypothesized that fever may play a role in helping 
fight malaria. In a study by Long et al., 2001, malaria parasite growth was observed to be 
inhibited at high temperatures in vitro66. 
Other symptoms, including hepatosplenomegaly, anemia and thrombocytopenia, 
are more prevalent in children in malaria endemic regions67–71. 
The various parasitic species do have some unique presentations. P. falciparum and 
P. vivax are the two most prevalent malaria species in India. P. vivax typically presents 
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with a sudden onset of a cold phase, followed by a hot phase and a sweating phase. The 
cold phase is characterized by pallor, chills and cutis anserina65,72,73. Patients may try to 
stay warm using blankets, with little success. The hot stage ensues with patients feeling 
very hot and vomiting. Headaches, altered awareness, dry throat, and diarrhea are not 
uncommon. Children may sometimes convulse. After about 2-6 hours, the patient enters 
the sweating phase. The patient begins to sweat profusely followed by a rapid decline in 
temperature. At this point, the patient begins to feel better, albeit with some degree of 
tiredness and the desire to sleep59. Hepatosplenomegaly may later be seen in the disease 
process in these patients.  
 P. vivax may remain in a latent stage in untreated patients. Weeks, months or even 
years after the primary infection, the disease can relapse with manifestation of clinical 
symptoms. Relapses usually last for a shorter time and are often less severe59.  
In P. falciparum malaria, flu-like symptoms are present in the prodromal phase. 
Patients may experience dry cough and tachypnea insinuating acute respiratory disease. 
Similar to P. vivax malaria, patients may have hepatosplenomegaly, jaundice and 
orthostatic hypertension. P. falciparum malaria is likely to progress to severe illness if not 
treated. On the other hand, the disease can be quickly treated with the right medications. 
P. falciparum can recur due to existing erythrocytic forms of the parasites. 
Severe malaria 
Severe malaria mostly stems from P. falciparum. It is present in both children and 
adults in low malaria endemic areas, but much more prevalent in young children in high 
malaria endemic areas. Other symptoms associated with severe falciparum malaria include 
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hypoglycemia, impaired consciousness, shock, pulmonary edema, jaundice, and renal 
impairment. Acidosis and hyperparasitemia with or without bleeding also occurs in all age 
groups. These symptoms can develop rapidly and can lead to death within hours or days59. 
The most prevalent finding in P. vivax malaria is severe anemia, particularly in 
pregnant women. This is usually not associated with the high parasite levels seen in severe 
P. falciparum. That is, P. vivax is able to cause severe anemia at lower parasitemias. 
Several studies have reported other severe symptoms associated with vivax malaria. These 
include kidney failure, severe jaundice, metabolic acidosis, splenic rupture, hypoglycemia, 
abnormal bleeding and hemodynamic shock. Vivax malaria can also cause low birth 
weight. 
Severe malaria is associated with high mortality; it is therefore important to 
recognize it to prevent death 
Malaria Control 
To eradicate malaria worldwide, populations need to have universal access to and 
implementation of preventive measures, with proper treatment of malaria cases that 
develop. Additionally, communities must be aware of these control measures and be able 
to implement them. Countries like the United States were able to eliminate malaria through 
practices aimed at modifying mosquito habitat74. Other countries such as Turkey saw a 
decline in malaria due to the emergence and use of Dichlorodiphenyltrichloroethane 
(DDT)75. Between 1950-1970, extensive use of DDT resulted in more than a 50% decline 
in malaria infections in many countries (reviewed in Shiff 2002)75.  There are currently 
several methods in place to help prevent malaria, though over time mosquito vectors 
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develop means to circumvent those methods if they are used ineffectively or in isolation. 
WHO recommends an integrated vector management approach that emphasizes linkages 
between the environment and health, optimizing benefits to both. An effective vector 
control method reduces vector population, which can result in a decrease in malaria 
morbidity and mortality. To effectively control malaria, both healthcare workers and the 
community need a combination of tools and approaches. 
Methods used for malaria vector elimination include aerial spraying (ultra-low 
volume); larvicide use (cupric arsetoarsenite, temephos or insect growth regulators); 
biological control of the mosquito ovum (fish, bacteria or fungi feeding); and male 
mosquito sterilization76. Mount et al., showed that ultra-low volume spray resulted in 89-
100% mortality of different mosquito species77. Environmental management has also 
proved beneficial in wetlands, coastlands, forest areas and non-agricultural man-made 
habitats, particularly in rural areas76. Research by Keiser et al., showed that environmental 
management can lead to an 88% reduction malaria transmission risk78.  
Long-life insecticide-treated nets (LLITN) are another way of preventing mosquito 
bites. LLITNs are an effective, cheap and easy to use method of malaria prevention. 
However, they only effective during sleep when slept under76. Traps have also been 
developed based on odors released by mosquito targets. Several studies have been 
performed to identify the target odors that will attract more mosquitos to the traps79–81.  
Further, a careful design of human settlements reduces malaria transmission by about 
96%82 . This approach involves covering windows and doors with net screens, blocking 
eaves, and installing ceilings. 
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Malaria in India 
India is the second-most populated country in the world, with more than 1.3 billion 
people. Its population is tremendously diverse, including various religious groups, ethnic 
groups, socioeconomic statuses and educational backgrounds. The country is made up of 
29 states and 7 union territories and occupies a large footprint (nearly 1.3 million mi2). Its 
terrain consists of wide desert areas, vast plains, hills and tall mountains, rain forests, rivers, 
waterfalls, beaches and two groups of islands. 
India has one of the fastest growing economies in the world83, yet it struggles with 
poverty and poor health84. In 2015, infant mortality was recorded at 38 deaths per 1,000 
live births, mortality for children under 5 at 48 per 1,000 live births and maternal mortality 
at 174 deaths per 100,000 live births85,86. Most of these deaths are recorded in malaria 
endemic districts. Despite these numbers, malaria control programs in India have paid little 
to no attention to malaria in pregnant women and their babies87.  
Malaria has posed a threat to India for centuries. In 1852, a recorded malaria 
epidemic wiped out the entire population of Ula in West Bengal state while causing havoc 
to nearby communities88. Railway introduction to India seems to have been both a blessing 
and a curse. While it provided a major opportunity for travel and business, the 
embankments used in railway construction served as breeding grounds for malaria 
parasites. Furthermore, the railway workers most likely (and unwittingly) helped spread 
the parasites as they moved from one area to the next. World War II also saw a significant 
increase in malaria-related cases and deaths in India88.  
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India first established malaria control programs in the 1900s, around railway and 
military areas. Following that, the National Malaria Control Programme (NMCP) was 
started in 1953. The NMCP focused on insecticidal residual spray use with DDT, the 
monitoring and surveillance of cases, and treatment of patients. Following the launch of 
NMCP, malaria-associated illnesses and deaths were significantly reduced over the 
following years (75 million malaria cases in 1953 to 2 million malaria cases 1958)89. 
During this period, India became a model for malaria control for developing countries 
worldwide90. Other control programs have been established since, including: The National 
Malaria Eradication Programme (1958), the Urban Malaria Scheme (1971), and the 
Modified Plan of Operations (1977), among others. Each program saw a decline in malaria 
cases after its establishment, though cases eventually rose again. The resurgence in cases 
was linked to poverty, lack of adequate health infrastructure for surveillance and logistical 
challenges in various parts of the country. Inadequate KAP may have interfered with the 
effectiveness of malaria control measures over the years91,92. 
India’s current focus is to eliminate malaria and to maintain a malaria-free zone by 
2030. To accomplish this goal, the country launched the National Framework for Malaria 
Elimination (NFME) in India 2016-2030 in February 2016. 
Indian tribal populations account for the greatest share of reported malaria cases 
(91%) and deaths (99%). The tribal populations live in certain states: Orissa, West Bengal, 
Andhra, Karnataka, Jharkhand, Madhya  Pradesh, Chhattisgarh, Maharashtra, 
Meghalaya, Mizoram, Odisha, Telegana and Tripura. These states are mostly forested, 
made up of foothills and located in conflict areas. 93. 
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Indian malaria transmission is largely seasonal-based and is termed “unstable 
transmission94.” This transmission is most prevalent before the monsoon rains and 
prevalent in all age groups, with pregnant women particularly at risk during epidemics95. 
People in unstable transmission regions are usually slow to develop natural immunity to 
malaria, leaving the majority of Indians at high risk of malaria infection96. The situation 
differs from Africa, where there is high and stable malaria transmission. As a result, 
Africans are able to develop incomplete immunity albeit the development of immunity 
requires several years of malaria exposure53,55,97,98. It should be noted that there are areas 
of stable transmission in India as well99.  
Malaria in pregnancy 
Studies by Lindsay et al., 2000, showed that malaria vectors predominant in Africa 
are highly attracted to pregnant women (mean, 6.33 per night [95% CI 4.5-8.7) than non-
pregnant women (3.1 [2.1-4.5]; p = 0.0002)100. The increased attraction has been attributed 
to physiological changes in pregnant women, such as increased carbon dioxide exhalation 
and greater skin emission of volatile substances and heat100,101. Pregnancy itself modifies 
the immune system resulting in a differential response to infection compared to non-
pregnant women102, making pregnant women more vulnerable to serious malaria illness 
upon infection103. The risk of infection and disease manifestation is additionally increased 
in primigravidas and in HIV-infected pregnant women104 as immunity further decreases. 
Upon malaria infection, pregnant women have a greater propensity to develop 
complications and ultimately death. Mortality rate in pregnant women with severe malaria 
approaches 50%22. Severe anemia represents a particular problem during malaria in 
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pregnancy. Generally, malaria-infected red blood cells get sequestered by the spleen, 
leading to increased erythroid hyperplasia, folic acid depletion and megaloblastic 
anemia105. In addition, infected erythrocytes are sequestered in the placenta of pregnant 
women106,107. These actions result in a higher rate of severe anemia in infected pregnant 
women. Such findings have highly been reported in malaria endemic regions, with 25% of 
severe anemia cases in pregnancy stemming from malaria104. Finally, children born to 
women with malaria during pregnancy and acute placental malaria infection are more 
susceptible to malaria infection during infancy and are at a high risk of infant death.108  
Some malaria-infected pregnant women remain asymptomatic due to the 
sequestration of the parasites in the placenta. These women sometimes have a high level 
of immunity, protecting them but putting their fetus at risk of malaria infection22. The 
placental sequestration of red blood cells alters oxygen and nutrient transfer to the fetus. 
Additionally, placental sequestration of infected erythrocytes, elicits a local monocyte 
inflammatory response109. Although the mechanisms are still unclear, these events in the 
placenta potentially result in spontaneous abortion, still birth, pre-term birth, or low-birth-
weight babies110. Low-birth-weight babies face an even high risk of death111.  
 Both the mother and the baby are at risk of severe malaria infection. The levels of 
parasites are high in this cohort, causing hypoglycemia, severe anemia and acute 
pulmonary edema in the mothers. Fetuses could once again be aborted due to fetal distress, 
and stillbirth is not uncommon. P. vivax infection leads to about a 107g reduction in birth 
weight, versus a 170g reduction in in P. falciparum infection112. 
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Malaria in pregnancy is an overlooked health crisis in India. Studies carried out in 
Central India by Singh et al., in 1999 showed that parasitemia, maternal mortality, and 
severe anemia, were predominant in pregnant women compared to non-pregnant women 
infected with either falciparum or vivax malaria14. In earlier studies in northwestern India, 
Kochar et al., had also showed a similar trend in pregnant women and their neonates113. 
The mortality rate in pregnant women with falciparum malaria infection was significantly 
higher (38%%) than in non-pregnant women (15%) with falciparum infection (p<0.001). 
A number of studies have been performed to estimate the burden of malaria in 
pregnancy in India. Dellicour et al., showed that among the world’s countries, India had 
the most pregnancies at risk of both falciparum and vivax malaria infection114. A study 
conducted in India’s Madhya Pradesh state, malaria prevalence in pregnant women was 
12.6% (OR of 7.61 at 95% CI (2.1 - 27.4)) vs 6.6% (OR of 1.73 at 95% CI (0.5 - 6.2)) in 
non-pregnant women of child-bearing age. Additionally, anemia was the predominant side 
effect in pregnant women with malaria (62.6%), as compared to non-pregnant women of 
child-bearing age (53.2%)115. Another study performed in Jharkhand state between 2006 
and 2007 showed that about 2% of women who attended antenatal clinics had malaria. In 
that same study, 4% of women in the delivery units had malaria infection, with 2% of that 
population having placental infection. P. falciparum accounted for 84% of in-patient 
diagnosed malaria in pregnancy, while P. vivax accounted for 8%16 . 
A recent study of malaria-infected women performed in a tertiary level medical 
college hospital in Kolkata, India, identified 77% of the malaria cases as caused by P. vivax. 
The remaining 23% were falciparum malaria cases. The complications identified in the 
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study were mostly caused by P. falciparum infection. The most common symptom present 
was anemia (84% of all cases), followed by 61% of women with affected placentas. Low 
birth weights and perinatal births were also reported in this study. Although disease 
prevalence was higher in primigravidas, disease severity was higher in multigravidas116. 
Moore et al., showed that out of 50,060 pregnant women followed in India, 16% 
(8,221) had malaria during their pregnancy. About 21% of the babies born to these women 
were small for their gestational age117. 
Several other studies in India have shown high prevalence of P. falciparum or P. 
vivax malaria and discussed their impact on pregnant women or their neonates44,118,119. The 
prevalence of malaria in this vulnerable population and the resulting impact also mean that 
both pregnant women and the children born to them are an important source of malaria 
transmission. 
Again, these various findings point to the focal nature of malaria prevalence in the 
country, a varied geoparasitological distribution nationwide and the need for focused 
malaria interventional methods. 
Malaria Prevention in Pregnancy 
Malaria is a preventable and treatable disease. There has been a reduction in malaria 
transmission worldwide, particularly in Africa. As already highlighted, some countries 
have also experienced total malaria elimination.  
Although there is little to no information on the specific impact of malaria 
preventive measures on pregnant women, overall the WHO reported significant cost 
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savings of U.S. $900 million from malaria control practices in Sub-Saharan Africa between 
2001-2014120. 
Most of these successes have been due to significant investments in and 
implementation of malaria control programs, in addition to the use of effective drug 
treatments121.   
Malaria prevention was one of the Millennium Development Goals122, with the aim 
of; 
1. Preventing malaria with long-lasting insecticidal nets and indoor residual spraying 
2. Testing and diagnosing with accuracy and treating with quality-assured anti-
malarial medicines 
3. Providing preventive therapies for infants, children and pregnant women 
4. Tracking every malaria case in a surveillance system 
5. Scaling up the fight against emerging drug and insecticide resistance 
The use of insecticide-treated bed nets (ITNs), including long-lasting insecticidal 
nets (LLINs), and intermittent preventive treatment in pregnancy (IPTP) have been the 
mainstay of malaria prevention methods. LLINs have been designed to kill mosquitoes for 
3 years and have been recommended by the WHO. ITN use has resulted in a reduction in 
malaria mortality and morbidity in pregnant women and children. It has also led to 
decreased maternal anemia, parasitemia, and low birth weight123,124. Despite the significant 
impact of ITN use, 47% of the world’s population at risk of malaria failed to sleep under 
mosquito nets in 2015120. Within the South-East Asia region, Stewart and Marchand 
showed that ITN use could serve as an efficient way of controlling malaria125. There is the 
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need for effective education, behavior change, and active participation on the part of 
individuals and communities for further progress. Past studies have shown that it has been 
easy to persuade traditional highland communities in India to commit to ITN use once they 
had been educated about the benefits and experienced them126. This indicates the possibility 
of modifying KAP of communities through education125 leading to effective use of ITNs.  
Indoor residual spraying (IRS) has been another successful malaria preventive 
method. It is a very effective way of reducing malaria transmission by directly killing 
mosquitoes. It involves spraying insecticides on potential dwelling areas for mosquitoes. 
In 2015, about 106 million people worldwide were protected from malaria by IRS120. 
IPTP entails administration of therapeutic doses of an effective antimalarial drug, 
currently sulfadoxine-pyrimethamine (SP), at least twice to all pregnant women. IPTP is 
offered as part of antenatal care services during the second and third trimesters, irrespective 
of the status of malaria infection. IPTP is recommended by the WHO and is well-
established in most stable malaria transmission settings. (The WHO also recommends that 
pregnant women receive both iron and folic acid supplements.) There has been significant 
success in IPTP preventing adverse outcomes from malaria infection during pregnancy127–
131. For example, Menendez et al., IPTP use during pregnancy resulted in 40% reduction 
(95% CI, 7.40–61.20]; p = 0.020) in the incidence of clinical malaria, and a 13% reduction 
of actively infected placentas (p = 0.002) But despite the positive results from using IPTP, 
about 30% of pregnant women in Africa receiving antenatal care did not receive IPTP, 
while others did not complete the course as recommended by the WHO120.  
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Other practices that could limit malaria transmission include controlling malaria 
mosquito larvae with larvicides and using window screens, window curtains, insecticide 
treated blankets and protective outfits, among others. With the exception of larvicides, 
however, these additional practices have not been recommended by the WHO. 
Malaria Treatment in Pregnancy 
If malaria prevention fails, pregnant women infected with malaria can still take the 
necessary steps to protect both themselves and their unborn children. However, the right 
diagnosis is essential to prevent unnecessary exposure to antimalarials and the development 
of drug-resistant malaria. The following medications can be used for malaria treatment in 
pregnant women: quinine, chloroquine, artemisinins, atovaquone-proguanil, and 
clindamycin26. Women in their second or third trimester with uncomplicated falciparum 
malaria are treated with artemisinin-based combination therapy26. Within the first three 
days of treatment, the short-acting artemisinin derivative causes a significant reduction in 
parasite numbers. The remaining parasites are eliminated by the long-acting partner drug 
which also acts as a prophylactic agent, thereby preventing new infections when serum 
drug levels are beyond the minimum inhibitory concentrations of the parasite132.  Women 
in their first semester are treated with quinine26. In India, chloroquine is recommended for 
P. vivax malaria133. The development of severe malaria is an emergency and therefore calls 
for immediate treatment. Quinine or artemisinin derivatives should be provided 
parenterally, preferably using the intravenous route. 
Knowledge about malaria treatment and therapeutic dose options is essential for effective 
management of malaria, especially among pregnant women and their unborn children. 
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Existing research 
Knowledge attitudes and practices of malaria prevention/treatment 
Globally, several studies have been conducted to identify the knowledge, attitudes 
and practices towards malaria prevention and treatment. The effectiveness of the various 
malaria preventive and treatment methods depend on the attitudes and knowledge of both 
individuals and the community as a whole. These attitudes and knowledge are shaped by 
social and cultural factors32.A study by Chapman in 2003 demonstrated the need for 
extensive qualitative research for providing a comprehensive understanding of pregnancy 
care134. Other studies have also demonstrated the need for recurring qualitative research on 
trends in thought, knowledge and beliefs towards malaria, as these seem to change with 
time135,136. 
A systematic review by Pell et al., was performed to examine KAP in MIP in 
Africa. The study found that pregnant women underestimated the seriousness of MIP due 
to locally defined reasons. First, malarial symptoms, because they are somewhat generic, 
can be attributed to other local illnesses. Pregnant women confused malaria symptoms with 
pregnancy symptoms, too. They further blamed their malarial symptoms on heat, cold, diet 
and/or physically strenuous work. Some pregnant women believe that malaria is a threat 
caused by witchcraft rather than by a parasite infection32. 
The WHO recommends at least eight antenatal care visits to reduce perinatal deaths 
and improve care during pregnancy138. These visits help ensure successful implementation 
of MIP interventions by providing timely and relevant information during pregnancy and 
also providing comprehensive and high-quality medical care, and support system where 
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necessary139. Thus antenatal clinics (ANCs) serve as important places to improve patient 
KAP towards malaria interventions. In a systematic study of developing countries by 
Simkhada et al., a pregnant woman’s education, travel costs and distance to an ANC 
influenced the likelihood that she would visit the ANC. Younger women also avoided ANC 
visits to hide their pregnancies, while older women indicated they had enough experience 
with pregnancy and therefore did not need ANC visits140,141. Some women thought ANCs 
were there just for pregnant women who are ill, failing to understand ANCS were also for 
well-pregnancy visits and preventive visits32. Failure to visit an ANC may explain the high 
negative impact of malaria in pregnancy in India and globally. Studies examining KAP in 
pregnant women who visit the ANC and those who do not are warranted to help ensure that 
pregnant women are receiving the benefit of preventing and treating malaria during ANC 
visits. 
In India, most studies on malaria KAP have focused on the general population.  For 
example, Vijaykumar et al., showed that 63% of respondents acknowledged mosquito bites 
as the cause of malaria142. Nevertheless, people from remote villages with malaria preferred 
to consult traditional healers. Among people who did not know the cause of malaria, 10% 
attributed the cause to dirty drinking water, hard work, tiredness or long exposure to the 
sun. Although 65% of the respondents recognized malaria as a serious disease, they 
described it that way because malaria infection hampered their day-to-day work, resulted 
in more money being invested in treatment and caused physical suffering142. Individuals in 
this setting may be amenable to malaria education that centers around the prevention and 
treatment of malaria to avoid falling sick and not being able to go to work. Others (27%) 
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did not consider malaria a serious disease, with the reason given that treatment was easily 
attainable. Furthermore, the authors found that 67% of people knew that malaria infection 
can be reduced through (insecticide-impregnated) mosquito net use, while 30% did not 
know how to reduce the risk of malaria infection142. Factors that have influenced seeking 
care for malaria have included the proximity of healthcare facilities to the homes of 
patients. Patients preferred to go to care providers  — whether traditional healers, 
community health workers or qualified doctors — whose care centers were situated in close 
proximity to their homes142,143.  
Similarly, studies in the Odisha state of India showed that patients were more likely 
to seek care from traditional healers or unqualified providers even when they had 
awareness of malaria-related symptoms144. The Odisha studies also showed that malaria 
patients were more likely to avoid treatment when it was offered by trained community 
health workers. The patients lacked trust in the health workers for the following reasons: 
drugs frequently out of stock144, drug side effects, doubts about drug quality and 
inappropriate provider behavior (some providers provide quick symptom relief through 
expensive antibiotic injections)143. 
Another study performed in malaria-endemic areas of India showed a lack of 
knowledge about malaria etiology and symptoms among tribal populations. In association 
with the lack of knowledge, patients presented to traditional healers or unqualified 
providers who lacked knowledge about malaria infection. The use of antimalarials and 
malaria preventive methods such as ITNs were reported to be low (50% of the tribal 
population). As in other studies, community health workers identified lack of transport as 
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a hindrance to malaria surveillance and proper prevention and treatment145.  In another 
study, health facilities in the Terai region of West Bengal, India, lacked the necessary 
infrastructure (such as blood testing units and antimalarial drugs) for malaria treatment, 
despite frequent outbreaks of malaria146 . 
In a study conducted in 200 households in urban regions of India, 92% of the people 
reported knowledge of malaria, but only 53% knew it was preventable. As a result, the use 
of ITNs and DDT spraying was very low147. Similar studies in parts of India have shown 
awareness of mosquitoes as transmitters of malaria, but low adoption of preventive 
measures148. A national study in India (n=1,000) showed a disconnect between knowledge 
of malaria prevention and prevention practices149.  
A recent cross-sectional survey in India showed 56% of the population had some 
knowledge about malaria but only 16% practiced good malaria preventive measures. As 
many as 82% of the respondents used self-medications150. Unlike the above studies, Sood 
et al., showed that good knowledge of LLINs positively impacted their use, which reduced 
malaria incidence. Knowledge of LLINs also positively influenced the purchase of LLINs. 
This study emphasized the need for and importance of effective malaria education that 
translates people’s knowledge of malaria into effective prevention methods151. As patients 
gained knowledge and experienced reduced malaria cases from LLIN use with minimal 
side effects, the use of LLINs became widely accepted. 
However, malaria KAP in healthcare workers as it relates to pregnant women is 
also essential, especially in situations where healthcare workers are the only source of 
accurate information for the general populace. Studies by Wylie et al., in two Indian states, 
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Jharkhand and Chhattisgarh, showed that the use of efficient malaria preventive methods 
like ITNs were low. Health workers in Jharkhand did not recommend ITN use during 
antenatal visits, though more than 90% of the pregnant women owned bed nets. In the same 
study, only 14% of health workers in Chhattisgarh recommended bed net use to pregnant 
women. The use of chloroquine as chemoprophylaxis or IPTP therapy was prescribed in 
only 0.7% and 0.1% of ANC visits, respectively99. In addition to the above published 
studies, several other studies performed in India reinforce these mixed findings152–158.  
Several studies point to the focal nature of factors influencing knowledge, attitudes 
and practices of malaria prevention and treatment worldwide. The impact and perceived 
value of KAP of malaria interventions varies with geographical location, respondent 
education level, gender, and socioeconomic status, as well as between pregnant women 
and non-pregnant women. A recent meta-analysis highlighted some factors that influence 
malaria prevention and treatment among pregnant women. These factors included poor 
knowledge of drug safety, self-medication practices, education, past miscarriages, 
antenatal care, adherence to treatment policies, patient preference for particular drugs, and 
drug availability and cost159.   
In general, women in some regions exhibit poor knowledge in malaria prevention 
and treatment practices. A cross sectional study by Sahoo et al., among residents in slum 
areas of India showed that awareness of malaria and other vector-borne diseases was 
significantly higher in males (65% in males vs. 46% in females), and literates (66% in 
literates with more than primary school education vs. 20% in people with primary or no 
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primary education)137. Females who were illiterate were especially likely to demonstrate 
poor malaria knowledge. 
A few qualitative studies have examined KAP in pregnant women in India. One 
study involving 31 pregnant women in government-run maternity hospitals in Mumbai 
showed respondents’ lack of concern about anemia during pregnancy. Anemia was seen as 
normal during pregnancy41. Although mild anemia is normal during pregnancy (50% 
increase in plasma volume expansion relative to 25% increase in erythrocytes)160, severe 
anemia from malaria is detrimental to the pregnant woman and the fetus. Indeed, a number 
of studies have shown that malaria prevention leads to a reduction in anemia during 
pregnancy161,162. It is important for pregnant mothers and health workers to identify severe 
anemia as a serious complication during pregnancy and its link to malaria to help save both 
the pregnant mother and the fetus. 
Another study conducted in some rural regions of India examined health 
information-seeking behaviors and perceived information support of low-income pregnant 
women. The data showed that lack of access to medical care negatively impacted the care 
and health practices of pregnant women. Patients resorted to knowledge from elderly 
women, friends and family to inform their decisions on disease prevention and treatment. 
All the women felt challenged by feelings of shame and embarrassment, including fear of 
repercussions from talking to their doctors about their pregnancies42. This psychological 
belief potentially hindered the women’s ability to obtain the necessary health information 
particularly as it relates to malaria in pregnancy. 
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In 2010, studies in the urban and rural areas of Jharkhand state in India assessed 
KAP in pregnant mothers. Pregnant women endorsed the use of unconventional methods 
for malaria prevention. These methods ranged from mantra reading to ingestion of 
concoctions and were influenced by their traditional beliefs and practices. Most pregnant 
women were unaware of chemoprophylaxis and ITN use for malaria prevention.  Pregnant 
women in this region preferred the use of untreated bed nets and non-modern methods for 
malaria prevention and treatment, though there was a desire to comply with instructions 
received from healthcare workers163. A more comprehensive study among pregnant women 
and caretakers in the urban and rural areas of Jharkhand and Chhattisgarh states has 
recently been performed. In this study, respondents from Chhattisgarh did not view malaria 
as a significant issue for pregnant women. Respondents from Jharkhand saw malaria as a 
threat to pregnant women, but they mostly resorted to traditional methods of malaria 
prevention. Interestingly, healthcare workers failed to effectively address malaria 
prevention and treatment methods during ANC visits 164.  
Altogether, KAP studies performed on malaria in pregnancy worldwide and in 
India suggest a culturally and locally defined outlook on the disease. Pregnant women, 
traditional healers, healthcare workers, and members of the community are all stakeholders 
in malaria prevention and treatment. The availability of antenatal clinics and other health 
care centers, the distance to health facilities, and the cost of and accessibility to preventive 
methods and medications all contribute to the effectiveness of malaria intervention 
methods. The views and practices of stakeholders help to provide a structural framework 
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targeting each society’s needs in curtailing malaria, particularly in vulnerable populations 
such as pregnant women. 
KAP studies can serve as an evidence-based tool for planning, refining and 
evaluating malaria policies in various countries. KAP studies help to identify general 
perceptions and attitudes held by individuals. They also bring to bear the factors that 
influence behaviors in most people. In the process, KAP studies help to define the right 
communication process for planning effective messages and activities for malaria 
prevention and treatment. This ensures effective use of the limited resources available for 
producing the preferred behavioral change and practice. KAP studies can also provide 
insight into problems, needs and barriers in malaria interventions. This helps identify the 
solutions needed for improving access and quality of services. To some extent, KAP studies 
can be used to identify ways to involve health providers in preventing and treating malaria. 
All in all, KAP studies can positively impact individual and community change by 1) 
mobilizing government resources, 2) improving malaria prevention, case detection and 
treatment adherence, and 3) combating incorrect dogmas.  
KAP could be improved by advocating, communicating and organizing activities 
for the community with the goal of educating them about malaria and its interventions165. 
Indeed, training programs to improve KAP on malaria prevention and control have 
successfully impacted the implementation of malaria prevention and treatment. For 
example, a study in Nigeria saw an increase in malaria knowledge of 66.7% after training. 
The training entailed organized lectures, health education and practical demonstration 
sessions166. Studies in some parts of India have shown the need to use culturally appropriate 
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health education materials, incorporate traditional healers into malaria control programs, 
and increase the availability of malaria prevention tools to communities, to increase KAP 
of malaria interventions167.  
To date, KAP in conflict areas of India have not been explored, though these are 
high malaria endemic areas. Assessing KAP in these regions has the potential to help 
improve the state of malaria among pregnant women.  
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METHODS 
Study design 
This study will be a cross-sectional qualitative study in Chhattisgarh, India, 
during which a question guide with open ended questions will be administered in a face-
to-face interview approach to examine pregnant women’s knowledge, attitudes and 
practices towards malaria prevention and treatment. 
 
Study population and sampling 
In India, Chhattisgarh is the state most affected by conflicts in tribal forested areas.  
These areas are burdened with illiteracy, poverty, overpopulation168  and malaria. Mobile 
Clinics (MCs) have been established in open areas in the closest possible proximity to 
homes169. MCs are organized by Médecins Sans Frontières India as a way to bring 
healthcare to people who are apprehensive about attending government hospitals and 
clinics. Clinic sessions are organized once a week to provide general care, antenatal care 
and post-natal care consultations, laboratory tests, and drug dispensation. These services 
are free of charge, creating an environment that allows the natives to visit without concern 
for cost. 
The study population will include pregnant women present in the conflict areas of 
Chhattisgarh. Eligibility includes women who are: 1) pregnant; 2) consent to taking part in 
the study; and 3) greater than 15 years of age. 
Based on past qualitative studies, saturation is reached after interviewing 6-12 
individuals with comparable backgrounds170. This study will enroll two groups of pregnant 
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women: those who visit the ANC clinics and those who do not. At least six women who 
have visited the ANC clinics and six women who have not visited the clinics will be 
recruited from each of the 7 districts (Bestar, Dantewda, Jashpur, Kanker, Kawarda, 
Rajnanadgaon, and Surguja) within the Chhattisgarh conflict region171.  Interviews will be 
conducted in each district for 2-3 weeks. Pregnant women will be given a bed net for their 
participation, an incentive successfully used in the previous studies. 
Data collection 
Data collection will be similar to the method used by Sabin et al.,163. Qualitative data will 
be collected by two trained local interviewers, focusing on malaria knowledge, malaria 
prevention and local health beliefs using a pre-tested, semi-structured question guide 
(Appendix 1). One interviewer will focus on obtaining the information and the second 
interviewer will record the responses, an accepted and successful practice used in previous 
studies40.  The interviews will be conducted in Hindi. All interviews will be recorded using 
a voice recorder, which is an acceptable practice in India.  
The question guide will be structured to enable open-ended exchanges. Each 
interview should take between 90-120 minutes to complete. The question guide will 
contain specific topics focused on 1) What do you do to protect yourself against malaria 
during pregnancy? 2) Have you been sick with malaria during a previous pregnancy or 
during this one? 3) If yes, what did you do? Other questions will target socio-demographic 
data, health concerns, and knowledge, perception, and behaviors regarding malaria. 
Respondents will also be asked about their use of modern and traditional malaria 
intervention methods. Daily reviews of collected data and recordings will be done by a 
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bilingual study member to ensure accurate Hindi language notes. The notes will then be 
translated into English, with verification by a second bilingual study member. 
Data analysis 
An analyst will code the responses using grounded theory172, analyze the resulting 
themes using Microsoft (Redmond, WA) Excel 2010, and perform a frequency analysis of 
the themes in relation to specific topics. Reponses made spontaneously or in reply to a 
follow-up question will be included in the frequency analysis. Responses will be prioritized 
based on the number of times they are mentioned. The analysis will also compare responses 
between districts, as well as by level of education and between pregnant women who 
visited the ANC and those who did not. 
Timeline and resources 
The study will be conducted over the course of one year (two to three weeks in each 
district). 
Institutional Review Board 
The study will be submitted for review by the Boston University Institutional 
Review Board and the MSF Ethical Review Board in Geneva, Switzerland. Patient 
information will be de-identified and data analyzed anonymously. Consent will be obtained 
from all respondents before participation.  
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CONCLUSION 
Discussion 
This study will be the first to examine the knowledge, attitudes and practices 
towards malaria prevention in pregnant women in the conflict forested areas of 
Chhattisgarh, India. Malaria in pregnancy (MIP) can cause severe anemia in the pregnant 
woman, with increased risk of post-partum bleeding and sometimes death111,173. MIP can 
also result in low birth weight or stillbirth. Despite ambitious goals and guidelines for 
malaria prevention in India, there is little attention paid to pregnant women and their 
unborn children. Additionally, insufficient progress has been made in controlling the 
disease nationwide. The success of MIP interventions in populations depends on 
understanding the impact of culture and tradition on the knowledge, perceptions and 
attitudes of the population, as well as on effective medication. This study will generate 
information that could help target policies for this vulnerable population with the goal of 
1) developing culturally sensitive and appropriate malaria preventive and treatment tools; 
2) improving cultural health beliefs through education; 3) encouraging healthcare workers 
to include examples from cultural backgrounds to help dispel myths and facilitate lifestyle 
changes in the context of where patients live and 4) providing easy access to modern 
methods of malaria prevention and treatment.     
This study could potentially be limited by the number of women who visit the MC 
for ANC.  The MCs were established to accommodate the fears and insecurities of the 
locals with the aim of encouraging clinic visits without any danger. Nevertheless, due to 
the conflict nature of these communities, patient visits to the MC may still be limited. It 
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has been estimated that only about 25% of pregnant women in the area access the MC ANC 
every year15. This means findings from our study potentially may not reflect the cultural 
views of all the pregnant women in the districts. However, the approach of also including 
women who do not visit the ANC ensures a diverse population and an adequate sample 
size reflecting the community. 
This study is focused on conflict tribal areas of India and thus findings from this 
study may not be applicable to other regions of India or the world. Furthermore, 
respondents, knowing their knowledge and awareness about malaria is being assessed, may 
exaggerate their responses. This may mask other views or behaviors that may be relevant 
for improving malaria prevention and treatment.  
Within the study population, patient knowledge and perceptions may be impacted 
by health workers influence. Since the MCs provide ANC and post-natal care 
consultations, access to these services may skew the knowledge and attitudes of pregnant 
women because they have received knowledge about malaria. On the other hand, if the 
knowledge of pregnant women who visit the ANC is found to be lacking, it may be a 
reflection of the kind of care and information being received from their care providers. 
Even if the ANC health workers were adequately trained, there is the need for a study that 
accesses the attitude and practice of these providers because several studies have shown 
health workers do not always recommend the necessary malaria interventions to their 
patients164,174. There are also obviously situations in which patients fail to follow 
recommendations provided by healthcare workers.  
 36 
Correct knowledge of malaria etiology and interventions among women who visit 
the ANC may suggest a potential positive impact of the health worker education. If 
pregnant women who attend the ANC are well-informed, the study may identify ways to 
encourage pregnant women who do not visit the ANC to do so, if their level of malaria 
knowledge and practices is found to be inadequate. 
Summary 
This study will highlight a number of malaria data points among pregnant women 
in conflict areas of Chhattisgarh, India: what they understand about the disease’s 
transmission, how they perceive its cause, whether they recognize its signs and symptoms, 
what treatment-seeking behaviors they exhibit, and what preventive measures and practices 
they employ.  
If this study finds poor knowledge and attitudes favoring traditional or unproven 
methods of malaria interventions, as shown in previous studies, then that may explain the 
current rate of MIP in these areas and demonstrate the need for specific interventions 
targeted to this population for the control and prevention of malaria.  
Since several policies and guidelines are being proposed in India and worldwide, 
there is the need to ensure that the general population is up-to-date on these guidelines and 
willing to embark on the measures needed to eliminate malaria. Knowledge gained from 
this study will help direct additional studies toward the neglected and vulnerable 
populations in India and help foster the country’s fight to end malaria by 2030. 
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Clinical and/or public health significance 
Malaria poses a significant health threat to pregnant women. If the data shows the 
need for improving KAP, governmental policies can be employed to help educate and 
implement malaria interventions, especially in conflict areas of India. Through this study, 
we will learn if pregnant women attending MCs in Chhattisgarh know more about malaria 
preventive measures and treatments than those who do not attend the clinics. Knowledge 
gained from this study could eventually help avoid the impact malaria has on pregnant 
women, such as severe anemia, and on their babies, such as low birth weight, preterm labor, 
and stillbirths. Indeed, studies in the Orissa state of India showed a correlation between 
high knowledge and malaria intervention utilization143, pointing to the fact that findings 
from this study can go a long way toward identifying customs, local beliefs and practices 
that have obstructed malaria prevention in pregnant mothers. This will help inform policies 
in this region of India, furthering the expectations of decreased malaria morbidity and 
mortality and increased GDP growth, as well as eventual achievement of India’s 
overarching goal of eliminating malaria by 2030. 
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APPENDIX 1 
Malaria in Pregnancy in Chhattisgarh, India 
IN-DEPTH INTERVIEW – Pregnant Women 
 
INTRODUCTION: Introduce yourself and other team members who are present, describe 
your roles, and explain that you hope the participant is comfortable and happy to participate 
in this interview. 
 
1. General Health Concerns: 
1.1 What do you consider to be the important health problems among pregnant women in 
this area? 
Possible probes:  
If they only mention their own problems -- What about for pregnant women in general?  
Can you think about other pregnant women you know – your relatives, your neighbors? 
 
If they only mention specific aches and pains -- What about any illnesses or diseases?  
 
Which of these do you consider the three most important? 
1.2 if malaria is mentioned:  
Why do you consider malaria as an important health problem? 
If malaria is not mentioned above:  
How important is malaria as a problem among pregnant women?  Why? 
 
2. Malaria Knowledge:  
 
2.1 (A) What do you think causes malaria? 
Possible probes:  
 
(B) If mosquito bite is not mentioned -- What about a mosquito bite? 
 
2.2 Can you describe some symptoms of malaria? 
If fever is not mentioned – What about fever? 
 
2.3 Can you name any treatments and/or specific medicines used in the treatment of 
malaria? 
 
2.4 How do you think malaria affects the health of pregnant women? 
 
2.5 If a pregnant woman has malaria, do you think it will affect the baby?  If yes, how? 
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2.6 Can you tell me some things you can do to prevent malaria in pregnancy? 
 
2.7 Which of the method(s) for preventing malaria in pregnancy do you think work(s) best? 
 
2.8 Why? 
 
3. Prevention: Personal Knowledge, Attitudes, and Behaviors:  
3.1 What do you do to protect yourself against malaria during pregnancy? 
 
Possible probes:  
What about protecting yourself from mosquito bites? 
Anything else?  
3.2 What traditional remedies do you use to protect yourself from malaria? 
Anything else?  
3.3 What newer (modern) methods do you use to protect yourself from malaria? 
Probes for modern methods:  
 
- Mosquito Coils / Mat / Liquidator  
- Insecticide Sprays  
- Regular Bed nets 
- Insecticide-treated Bed nets  
- Malaria prophylaxis (Drugs to prevent malaria)  
Ask for each, if one or more of the above is mentioned:  
 
3.4 Can you tell me more about that?   
 
(a)  How often do you use xx? 
(b)  Is there anywhere that you can get it for free?  
(c What is the availability?  
(d)  How much do they/does it cost?  
(e)  How affordable are they/is it?  
(f)   Do you like use it? 
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3.5 For each of the newer (modern) methods not mentioned, ask specifically about each 
one.  For those that are used, ask the following: 
 
(a)  How often do you use xx?  
(b)  Is there anywhere that you can get for free?  
(c)  What is the availability?  
(d)  How much do they/does it cost?  
(e)  How affordable are they/is it?  
(f)   Do you like to use it?  
3.6 For each of the modern methods that are not being used:  
 
(a) Why not?  
 
(b) Do you know if there is anywhere that you can get it for free?  
 
(c) Do you know if it is available in this community?  
 
(d) Do you know how much it costs?  
 
(e) Do you know how affordable it is?  
 
(f)   Do you like to use it?  
 
3.7 Would you be willing to try a different method? 
 
Which one?  For each one mentioned: why?  
 
3.8 Is there a bed net in your house? 
 
(If participant already mentioned using a bed net, change to: You already told me about 
using a bed net.  Can you tell me more about bed nets?  And go to (a) below. 
 
3.9 If Yes: 
(a)  Who sleeps under bed nets? 
(b) Who decides who sleeps under bed nets?  
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(c)  What benefit is there from sleeping under a bed net?  
4. Prevention: Antenatal Care Emphasis on Malaria  
4.1 Do you routinely go to the clinic for antenatal care? 
4.2 If yes: (If no, skip to 5 below)  
(a) What advice or counseling on malaria have you been given by your health worker 
during your antenatal visits? 
 
(b) Was malaria emphasized as a major concern for pregnant women? 
 
5. Treatment of Malaria During Pregnancy:  
 
5.1 Have you been sick with fever or had a febrile episode during this pregnancy or any 
other pregnancy? (if no, skip to 5.3 below) 
 
5.2 If yes, was it due to malaria?  
If yes:  
 
(a) what did you do?  
(b) Where did you go?  
(c) Why did you go there?  
(d) Did you take any medicines?  If yes, which ones?  How did you get them? Were 
they affordable? 
(e) How did you take them? (Refers to oral vs. injection)  
If no, please tell me about the last time you had a fever: 
 
(a) what did you do? 
(b) Where did you go? 
(c) Why did you go there? 
(d) Did you take any medicines?  If yes, which ones?  How did you get them? Were 
they affordable? 
 
(e) How did you take them? 
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(f) If she didn’t take any medicines, why not?  
 
(g) What traditional remedies did you take?  Why did you take/use that one/those?  
 
5.3 If she has not been sick with fever and/or malaria; 
 
(a) What would you do if you get sick with fever or malaria during this pregnancy? 
 
(b) Where will you go? Why there? 
 
(c) What medicines will you take? How will you get them? How will you take them? 
 
(d)If she will not take any medicines, why not? 
 
(e) What traditional remedies will you take?  Why that one/those? 
 
5.4 Do you have concerns (or worries) regarding malaria treatments during pregnancy? 
 
(a) What are they? 
 
(b) Are you concerned that the medicines are dangerous for the baby? 
 
 (c) If yes, what are your concerns?  
6. Others: 
6.1 How do you get information about malaria during pregnancy? 
 
6.2 If no, do you know where to get information about malaria? 
 
6.3 If yes, which of these sources do you believe is/are the most reliable source(s) of 
information? 
 
6.4 (A) Can you tell me about traditional rituals related to pregnancy and malaria in this 
area? 
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(B) Do you practice them? 
 
6.5 Is there anything else you would like to share? 
 
 
Check that you have collected: 
 
 A RANKING OF THE IMPORTANCE OF THE HEALTH PROBLEMS NAMED 
(1.1) 
 THE MAIN WAYS THAT PREGNANT WOMEN IN THIS AREA PROTECT 
THEMSELVES AGAINST MALARIA (3.1 - 3.3)  
 WHY/WHY NOT PREGNANT WOMEN USE CERTAIN STRATEGIES TO 
PROTECT THEMSELVES AGAINST MALARIA (3.4 - 3.6) 
 WHETHER THEY WOULD TAKE MEDICINES IF PREGNANT AND IF NOT, 
WHY NOT (5.2, 5.3) 
 
THANK THE PARTICIPANT FOR HER TIME AND ASK IF SHE HAS ANY 
QUESTIONS 
 
 
  
 44 
LIST OF JOURNAL ABBREVIATIONS 
Acta Trop Acta Tropica 
Am J Public Heal Res American Journal of Public Health Research 
Am J Trop Med Hyg The American Journal of Tropical Medicine and Hygiene 
Ann Top Med Parasitol Annals of Tropical Medicine and Parasitology 
Anthropol Med Anthropology and Medicine 
Biomed Res Int Biomed Research International 
BMC Med BMC Medicine 
Bull World Health 
Organ 
Bulletin of the World Health Organization 
Clin Infect Dis Clinical Infectious Diseases 
Confl Health Conflict and Health 
Curr Sci Current Science 
Dengue Bull Dengue Bulletin 
Indian J Malariol Indian Journal of Malariology 
Indian J Med Res Indian Journal of Medical Research 
Indian J Pediatr Indian Journal Of Pediatrics 
Infect Immun Infection and Immunity 
Int J Confl Violence International Journal of Conflict and Violence 
Int J Med Sci Public 
Heal 
International Journal of Medical Science and Public Health 
 45 
Int J Mosq Res International Journal of Mosquito Research 
J Adv Nurs Journal of Advanced Nursing 
J Biosci Journal of Bioscience 
J Clin Diagn Res Journal of Clinical and Diagnostic Research 
J Fam Med Prim care Journal of Family Medicine and Primary Care 
J Infect Dis Journal of Infectious Diseases 
J Vector Borne Dis Journal of Vector Borne Diseases 
Lancet Infect Dis Lancet Infectious Diseases 
Malar J Malaria Journal 
Matern Child Health J Maternal Child Health Journal 
Mem Inst Oswaldo 
Cruz 
Memorias do Instituto Oswaldo Cruz 
Parasit Vectors Parasites and Vectors 
PLoS Med PLoS Medicine 
Soc Sci Med Social Science and Medicine 
Trans R Soc Trop Med 
Hyg 
Transactions of the Royal Society of Tropical Medicine and 
Hygiene 
Trends Parasitol Trends in Parasitology 
Trop med In Health Tropical Medicine and International Health 
Yale J Biol Med Yale Journal of Biology and Medicine 
  
 46 
REFERENCES 
 
1.  WHO I. World Health Organization,  Malaria. SEARO. 
http://www.searo.who.int/india/topics/malaria/en/. Published 2017. Accessed July 
31, 2017. 
2.  Directorate General of Health Services; Ministry of Health and Family Welfare; 
Government of India. NVBDCP | National Vector Borne Disease Control 
Programme: MAGNITUDE OF THE PROBLEM. 
http://nvbdcp.gov.in/malaria3.html. Accessed August 17, 2017. 
3.  Dhingra N, Jha P, Sharma VP, et al. Adult and child malaria mortality in India: a 
nationally representative mortality survey. Lancet (London, England). 
2010;376(9754):1768-1774. doi:10.1016/S0140-6736(10)60831-8. 
4.  Hay SI, Gething PW, Snow RW, al.  et, al.  et. India’s invisible malaria burden. 
Lancet. 2010;376(9754):1716-1717. doi:10.1016/S0140-6736(10)61084-7. 
5.  Sharma VP. Continuing challenge of malaria in India. Curr Sci. 102:678-682. 
doi:10.2307/24084452. 
6.  Gupta I, Chowdhury S. Economic burden of malaria in India: The need for effective 
spending. WHO South-East Asia J Public Heal. 3(1). doi:10.4103/2224-
3151.115828. 
7.  Snow RW, Okiro EA, Gething PW, Atun R, Hay SI. Equity and adequacy of 
international donor assistance for global malaria control: an analysis of populations 
at risk and external funding commitments. Lancet (London, England). 
2010;376(9750):1409-1416. doi:10.1016/S0140-6736(10)61340-2. 
 47 
8.  Wangdi K, Gatton ML, Kelly GC, Banwell C, Dev V, Clements ACA. Malaria 
elimination in India and regional implications. Lancet Infect Dis. 2016;16(10):e214-
e224. doi:10.1016/S1473-3099(16)30123-2. 
9.  Basu S, Sahi PK. Malaria: An Update. Indian J Pediatr. 2017;84(7):521-528. 
doi:10.1007/s12098-017-2332-2. 
10.  Greenwood B, Alonso P, ter Kuile FO, Hill J, Steketee RW. Malaria in pregnancy: 
priorities for research. Lancet Infect Dis. 2007;7(2):169-174. doi:10.1016/S1473-
3099(07)70028-2. 
11.  Directorate of National Vector Borne Disease Control Programme, Directorate 
General of Health Services, Ministry of Health & Family Welfare, Government of 
India. Strategic Plan for Malaria Control in India 2012-2017, A Five-Year Strategic 
Plan.; 2012. http://nvbdcp.gov.in/Doc/Strategic-Action-Plan-Malaria-2012-17-
Co.pdf. Accessed July 19, 2017. 
12.  Radeva-Petrova D, Kayentao K, ter Kuile FO, Sinclair D, Garner P. Drugs for 
preventing malaria in pregnant women in endemic areas: any drug regimen versus 
placebo or no treatment. In: Garner P, ed. Cochrane Database of Systematic 
Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2014:CD000169. 
doi:10.1002/14651858.CD000169.pub3. 
13.  Guyatt HL, Snow RW. Impact of Malaria during Pregnancy on Low Birth Weight 
in Sub-Saharan Africa. Clin Microbiol Rev. 2004;17(4):760-769. 
doi:10.1128/CMR.17.4.760-769.2004. 
14.  Singh N, Shukla MM, Sharma VP. Epidemiology of malaria in pregnancy in central 
 48 
India. Bull World Health Organ. 1999;77(7):567-572. 
http://www.ncbi.nlm.nih.gov/pubmed/10444880. Accessed July 24, 2017. 
15.  Corrêa G, Das M, Kovelamudi R, et al. High burden of malaria and anemia among 
tribal pregnant women in a chronic conflict corridor in India. Confl Health. 
2017;11(1):10. doi:10.1186/s13031-017-0113-1. 
16.  Hamer DH, Singh MP, Wylie BJ, et al. Burden of malaria in pregnancy in Jharkhand 
State, India. Malar J. 2009;8(1):210. doi:10.1186/1475-2875-8-210. 
17.  Singh N, Singh MP, Wylie BJ, et al. Malaria prevalence among pregnant women in 
two districts with differing endemicity in Chhattisgarh, India. Malar J. 
2012;11(1):274. doi:10.1186/1475-2875-11-274. 
18.  Kumar A, Valecha N, Jain T, Dash AP. Burden of malaria in India: retrospective 
and prospective view. Am J Trop Med Hyg. 2007;77(6 Suppl):69-78. 
http://www.ncbi.nlm.nih.gov/pubmed/18165477. Accessed December 27, 2017. 
19.  Sholapurkar SL, Gupta AN, Mahajan RC. Clinical course of malaria in pregnancy-
-a prospective controlled study from India. Trans R Soc Trop Med Hyg. 
1988;82(3):376-379. http://www.ncbi.nlm.nih.gov/pubmed/3068848. Accessed 
July 19, 2017. 
20.  Luxemburger C, Ricci F, Nosten F, Raimond D, Bathet S, White NJ. The 
epidemiology of severe malaria in an area of low transmission in Thailand. Trans R 
Soc Trop Med Hyg. 1997;91(3):256-262. doi:10.1016/S0035-9203(97)90066-3. 
21.  Poespoprodjo JR, Fobia W, Kenangalem E, et al. Adverse pregnancy outcomes in 
an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum 
 49 
infections are endemic. Clin Infect Dis. 2008;46(9):1374-1381. 
doi:10.1086/586743. 
22.  Monif GRG, Baker DA. Infectious Diseases in Obstetrics and Gynecology. 5th ed. 
Informa Healthcare; 2004. 
23.  Nosten F, McGready R, Mutabingwa T, et al. Case management of malaria in 
pregnancy. Lancet Infect Dis. 2007;7(2):118-125. doi:10.1016/S1473-
3099(07)70023-3. 
24.  Brooks MI, Singh N, Hamer DH. Control measures for malaria in pregnancy in 
India. Indian J Med Res. 2008;128(3):246-253. 
http://www.ncbi.nlm.nih.gov/pubmed/19052334. Accessed July 19, 2017. 
25.  Takem EN, D’Alessandro U. Malaria in pregnancy. Mediterr J Hematol Infect Dis. 
2013;5(1):e2013010. doi:10.4084/MJHID.2013.010. 
26.  WHO. Guidelines for the Treatment of Malaria-3rd Edition.; 2015. www. Accessed 
July 31, 2017. 
27.  World Health Organization. A Framework for Malaria Elimination.; 2017. 
http://apps.who.int/iris/bitstream/10665/254761/1/9789241511988-eng.pdf?ua=1. 
Accessed August 21, 2017. 
28.  Vector N, Disease B, Programme C, Welfare F. Operational Manual for Malaria 
Elimination in India. file:///C:/Users/USER/Desktop/Operational-Manual-Malaria-
2016-Version-1.pdf. 
29.  Kumar A, Chery L, Biswas C, et al. Malaria in South Asia: Prevalence and control. 
Acta Trop. 2012;121(3):246-255. doi:10.1016/j.actatropica.2012.01.004. 
 50 
30.  Dash AP, Valecha N, Anvikar AR, Kumar A. Malaria in India: Challenges and 
opportunities. J Biosci. 2008;33(4):583-592. doi:10.1007/s12038-008-0076-x. 
31.  Korenromp E. MALARIA INCIDENCE ESTIMATES AT COUNTRY LEVEL FOR 
THE YEAR 2004 – PROPOSED ESTIMATES AND DRAFT REPORT.; 2005. 
http://www.who.int/malaria/publications/atoz/incidence_estimations2.pdf?ua=1. 
Accessed July 19, 2017. 
32.  Pell C, Straus L, Andrew EVW, Meñaca A, Pool R. Social and Cultural Factors 
Affecting Uptake of Interventions for Malaria in Pregnancy in Africa: A Systematic 
Review of the Qualitative Research. Ellis RD, ed. PLoS One. 2011;6(7):e22452. 
doi:10.1371/journal.pone.0022452. 
33.  Hill J, Kayentao K, Achieng F, et al. Access and Use of Interventions to Prevent and 
Treat Malaria among Pregnant Women in Kenya and Mali: A Qualitative Study. 
Luty AJF, ed. PLoS One. 2015;10(3):e0119848. doi:10.1371/journal.pone.0119848. 
34.  Rassi C, Graham K, Mufubenga P, King R, Meier J, Gudoi SS. Assessing supply-
side barriers to uptake of intermittent preventive treatment for malaria in pregnancy: 
a qualitative study and document and record review in two regions of Uganda. Malar 
J. 2016;15(1):341. doi:10.1186/s12936-016-1405-4. 
35.  Rassi C, Graham K, King R, Ssekitooleko J, Mufubenga P, Gudoi SS. Assessing 
demand-side barriers to uptake of intermittent preventive treatment for malaria in 
pregnancy: a qualitative study in two regions of Uganda. Malar J. 2016;15(1):530. 
doi:10.1186/s12936-016-1589-7. 
36.  Hill J, Hoyt J, van Eijk AM, et al. Factors Affecting the Delivery, Access, and Use 
 51 
of Interventions to Prevent Malaria in Pregnancy in Sub-Saharan Africa: A 
Systematic Review and Meta-Analysis. PLoS Med. 2013;10(7). 
doi:10.1371/journal.pmed.1001488. 
37.  Ribera JM, Hausmann-Muela S, D’Alessandro U, Grietens KP. Malaria in 
Pregnancy: What Can the Social Sciences Contribute? PLoS Med. 2007;4(4):e92. 
doi:10.1371/journal.pmed.0040092. 
38.  Amoran OE. Impact of health education intervention on malaria prevention 
practices among nursing mothers in rural communities in Nigeria. Niger Med J. 
2013;54(2):115-122. doi:10.4103/0300-1652.110046. 
39.  Salam RA, Das JK, Lassi ZS, Bhutta ZA. Impact of community-based interventions 
for the prevention and control of malaria on intervention coverage and health 
outcomes for the prevention and control of malaria. Infect Dis poverty. 2014;3:25. 
doi:10.1186/2049-9957-3-25. 
40.  Sabin LL, Rizal A, Brooks MI, et al. Attitudes, knowledge, and practices regarding 
malaria prevention and treatment among pregnant women in Eastern India. Am J 
Trop Med Hyg. 2010;82(6):1010-1016. doi:10.4269/ajtmh.2010.09-0339. 
41.  Chatterjee N, Fernandes G. “This is normal during pregnancy”: A qualitative study 
of anaemia-related perceptions and practices among pregnant women in Mumbai, 
India. Midwifery. 2014;30(3):e56-e63. doi:10.1016/j.midw.2013.10.012. 
42.  Das A, Sarkar M. Pregnancy-related health information-seeking behaviors among 
rural pregnant women in India: validating the Wilson model in the Indian context. 
Yale J Biol Med. 2014;87(3):251-262. 
 52 
http://www.ncbi.nlm.nih.gov/pubmed/25191141. Accessed July 31, 2017. 
43.  Doctors Without Borders/ Médecins Sans Frontières (MSF). Essential healthcare in 
remote areas of Andhra Pradesh, Chhattisgarh, and Telangana | MSF India. 
https://www.msfindia.in/essential-healthcare-remote-areas-andhra-pradesh-
chhattisgarh-and-telangana. Accessed October 16, 2017. 
44.  Corrêa G, Das M, Kovelamudi R, et al. High burden of malaria and anemia among 
tribal pregnant women in a chronic conflict corridor in India. Confl Health. 
2017;11(1):10. doi:10.1186/s13031-017-0113-1. 
45.  NVBDCP. Malaria Situation.; 2017. http://nvbdcp.gov.in/Doc/malaria-situation-
May17.pdf. Accessed October 16, 2017. 
46.  State Health Resource Centre C. Community Based Monitoring of Health in 
Chhattisgarh, Draft Report 2013-14.; 2014. 
http://www.shsrc.org/webupload/MITANIN_PROGRAMME_AND_COMMUNI
TY_PROCESSES/VHSNC_CBM_AND_SPY_STUDIES/CBM_Report_2013_14.
pdf. Accessed October 16, 2017. 
47.  Diamond-Smith N, Singh N, Gupta R Das, et al. Estimating the burden of malaria 
in pregnancy: a case study from rural Madhya Pradesh, India. Malar J. 2009;8(1):24. 
doi:10.1186/1475-2875-8-24. 
48.  World Health Organization. WHO | 10 facts on malaria. WHO. 
http://www.who.int/features/factfiles/malaria/en/. Published 2016. Accessed 
August 14, 2017. 
49.  World Health Organization 2017. World Malaria Report 2017.; 2017. 
 53 
http://apps.who.int/iris/bitstream/10665/259492/1/9789241565523-eng.pdf?ua=1. 
Accessed December 28, 2017. 
50.  World Health Organization. World Malaria Report 2016.; 2016. 
http://apps.who.int/iris/bitstream/10665/252038/1/9789241511711-eng.pdf. 
Accessed July 31, 2017. 
51.  Cowman AF, Healer J, Marapana D, Marsh K. Malaria: Biology and Disease. Cell. 
2016;167(3):610-624. doi:10.1016/j.cell.2016.07.055. 
52.  CDC - Centers for Disease Control and Prevention. Human Factors and Malaria. 
https://www.cdc.gov/malaria/about/biology/human_factors.html. Accessed 
October 17, 2017. 
53.  COHEN S, McGREGOR IA, CARRINGTON S. Gamma-Globulin and Acquired 
Immunity to Human Malaria. Nature. 1961;192(4804):733-737. 
doi:10.1038/192733a0. 
54.  Sabchareon A, Burnouf T, Ouattara D, et al. Parasitologic and clinical human 
response to immunoglobulin administration in falciparum malaria. Am J Trop Med 
Hyg. 1991;45(3):297-308. http://www.ncbi.nlm.nih.gov/pubmed/1928564. 
Accessed October 17, 2017. 
55.  Treatment of east african P. falciparum malaria with west african human γ-globulin. 
Trans R Soc Trop Med Hyg. 1963;57(3):170-175. doi:10.1016/0035-
9203(63)90058-0. 
56.  Doolan DL, Dobaño C, Baird JK. Acquired immunity to malaria. Clin Microbiol 
Rev. 2009;22(1):13-36, Table of Contents. doi:10.1128/CMR.00025-08. 
 54 
57.  Marsh K, Snow RW. Host-parasite interaction and morbidity in malaria endemic 
areas. Philos Trans R Soc B Biol Sci. 1997;352(1359):1385. 
doi:10.1098/RSTB.1997.0124. 
58.  Amaratunga C, Lopera-Mesa TM, Brittain NJ, et al. A Role for Fetal Hemoglobin 
and Maternal Immune IgG in Infant Resistance to Plasmodium falciparum Malaria. 
Gruner AC, ed. PLoS One. 2011;6(4):e14798. doi:10.1371/journal.pone.0014798. 
59.  Bartoloni A, Zammarchi L. Clinical aspects of uncomplicated and severe malaria. 
Mediterr J Hematol Infect Dis. 2012;4(1). doi:10.4084/MJHID.2012.026. 
60.  Phillips A, Bassett P, Zeki S, Newman S, Pasvol G. Risk Factors for Severe Disease 
in Adults with Falciparum Malaria. Clin Infect Dis. 2009;48(7):871-878. 
doi:10.1086/597258. 
61.  Mota MM, Pradel G, Vanderberg JP, et al. Migration of Plasmodium Sporozoites 
Through Cells Before Infection. Science (80- ). 2001;291(5501):141-144. 
doi:10.1126/science.291.5501.141. 
62.  Sturm A, Amino R, van de Sand C, et al. Manipulation of host hepatocytes by the 
malaria parasite for delivery into liver sinusoids. Science. 2006;313(5791):1287-
1290. doi:10.1126/science.1129720. 
63.  Weiss GE, Gilson PR, Taechalertpaisarn T, et al. Revealing the Sequence and 
Resulting Cellular Morphology of Receptor-Ligand Interactions during Plasmodium 
falciparum Invasion of Erythrocytes. Blackman MJ, ed. PLOS Pathog. 
2015;11(2):e1004670. doi:10.1371/journal.ppat.1004670. 
64.  Simpson JA, Aarons L, Collins WE, Jeffery GM, White NJ. Population dynamics 
 55 
of untreated Plasmodium falciparum malaria within the adult human host during the 
expansion phase of the infection. Parasitology. 2002;124(Pt 3):247-263. 
http://www.ncbi.nlm.nih.gov/pubmed/11922427. Accessed August 1, 2017. 
65.  Warrell D. Clinical Features of Malaria. In: Gilles HM W DA, ed. Bruce-Chwatt’s 
Essential Malariology. Third Edit. London: A Hodder Arnold Publication; 1993:35-
49. 
66.  Long HY, Lell B, Dietz K, Kremsner PG. Plasmodium falciparum: in vitro growth 
inhibition by febrile temperatures. Parasitol Res. 2001;87(7):553-555. 
http://www.ncbi.nlm.nih.gov/pubmed/11484852. Accessed August 16, 2017. 
67.  Stein CM, Gelfand M. The clinical features and laboratory findings in acute 
Plasmodium falciparum malaria in Harare, Zimbabwe. Cent Afr J Med. 
1985;31(9):166-170. http://www.ncbi.nlm.nih.gov/pubmed/3910259. Accessed 
August 16, 2017. 
68.  Olaleye BO, Williams LA, D’Alessandro U, et al. Clinical predictors of malaria in 
Gambian children with fever or a history of fever. Trans R Soc Trop Med Hyg. 
1998;92(3):300-304. doi:10.1016/S0035-9203(98)91021-5. 
69.  Schellenberg D, Menendez C, Kahigwa E, et al. African children with malaria in an 
area of intense Plasmodium falciparum transmission: features on admission to the 
hospital and risk factors for death. Am J Trop Med Hyg. 1999;61(3):431-438. 
http://www.ncbi.nlm.nih.gov/pubmed/10497986. Accessed August 16, 2017. 
70.  Norhayati M, Rohani AK, Hayati MI, et al. Clinical features of malaria in Orang 
Asli population in Pos Piah, Malaysia. Med J Malaysia. 2001;56(3):271-274. 
 56 
http://www.ncbi.nlm.nih.gov/pubmed/11732070. Accessed August 16, 2017. 
71.  D’Acremont V, Landry P, Mueller I, Pécoud A, Genton B. Clinical and laboratory 
predictors of imported malaria in an outpatient setting: an aid to medical decision 
making in returning travelers with fever. Am J Trop Med Hyg. 2002;66(5):481-486. 
http://www.ncbi.nlm.nih.gov/pubmed/12201580. Accessed August 16, 2017. 
72.  Harinasuta, T; Bunnag D. The clinical features of malaria. In: Wernsdorfer, WH: 
McGregor I, ed. Malaria: Principles and Practice of Malariology. Vol 1. Churchill 
Livingstone, Edinburgh; 1988:709-734. 
73.  White NJ, Pongtavornpinyo W, Maude RJ, et al. Hyperparasitaemia and low dosing 
are an important source of anti-malarial drug resistance. Malar J. 2009;8(1):253. 
doi:10.1186/1475-2875-8-253. 
74.  Desowitz R. Milestones and Milstones in the History of Malaria. In: Mats Wahlgren 
PP, ed. Malaria| Molecular and Clinical Aspects . 1st ed. Taylor & Francis Group; 
1999. https://www.taylorfrancis.com/books/e/9781482298246. Accessed January 5, 
2018. 
75.  Shiff C. Integrated approach to malaria control. Clin Microbiol Rev. 
2002;15(2):278-293. doi:10.1128/CMR.15.2.278-293.2002. 
76.  Sibanda MM, Focke WW, Heyman HM, Birkholtz L-M. Physical, chemical and 
biological strategies to combat malaria. 
http://www.up.ac.za/media/shared/Legacy/sitefiles/file/44/1026/2163/8121/innovat
e8/4045physical_chemical_and_biological_strategies_to_combat_malariabymthok
ozisimsibandaetal.pdf. Accessed January 4, 2018. 
 57 
77.  Mount GA, Biery TL, Haile DG. A review of ultralow-volume aerial sprays of 
insecticide for mosquito control. J Am Mosq Control Assoc. 1996;12(4):601-618. 
http://www.ncbi.nlm.nih.gov/pubmed/9046465. Accessed January 4, 2018. 
78.  Keiser J, Singer BH, Utzinger J. Reducing the burden of malaria in different eco-
epidemiological settings with environmental management: a systematic review. 
Lancet Infect Dis. 2005;5(11):695-708. doi:10.1016/S1473-3099(05)70268-1. 
79.  Smallegange RC, Qiu YT, van Loon JJA, Takken W. Synergism between ammonia, 
lactic acid and carboxylic acids as kairomones in the host-seeking behaviour of the 
malaria mosquito Anopheles gambiae sensu stricto (Diptera: Culicidae). Chem 
Senses. 2005;30(2):145-152. doi:10.1093/chemse/bji010. 
80.  Okumu FO, Killeen GF, Ogoma S, et al. Development and Field Evaluation of a 
Synthetic Mosquito Lure That Is More Attractive than Humans. Rénia L, ed. PLoS 
One. 2010;5(1):e8951. doi:10.1371/journal.pone.0008951. 
81.  Mboera LE, Takken W, Sambu EZ. The response of Culex quinquefasciatus 
(Diptera: culicidae) to traps baited with carbon dioxide, 1-octen-3-ol, acetone, 
butyric acid and human foot odour in Tanzania. Bull Entomol Res. 2000;90(2):155-
159. http://www.ncbi.nlm.nih.gov/pubmed/10948375. Accessed January 4, 2018. 
82.  Lindsay SW, Emerson PM, Charlwood JD. Reducing malaria by mosquito-proofing 
houses. Trends Parasitol. 2002;18(11):510-514. 
http://www.ncbi.nlm.nih.gov/pubmed/12473368. Accessed August 2, 2017. 
83.  The World Bank. India Development Update: Unlocking Women’s Potential.; 2017. 
http://documents.worldbank.org/curated/en/107761495798437741/pdf/115297-
 58 
WP-P146674-PUBLIC.pdf. Accessed December 28, 2017. 
84.  GBD 2015 Healthcare Access and Quality Collaborators. Ryan M, GBD 2015 
Healthcare Access and Quality Collaborators N, Sorensen RJD, et al. Healthcare 
Access and Quality Index based on mortality from causes amenable to personal 
health care in 195 countries and territories, 1990-2015: a novel analysis from the 
Global Burden of Disease Study 2015. Lancet (London, England). 
2017;390(10091):231-266. doi:10.1016/S0140-6736(17)30818-8. 
85.  WHO, UNICEF, UNFPA, World Bank Group  and UNPD, Maternal Mortality 
Estimation Inter-Agency Group. Maternal Mortality in 1990-2015.; 2016. 
http://www.who.int/gho/maternal_health/countries/ind.pdf. Accessed August 16, 
2017. 
86.  You D, Hug L, Ejdemyr S, et al. Levels and Trends in Child Mortality Report 2015.; 
2015. http://www.childmortality.org/files_v20/download/IGME report 2015 child 
mortality final.pdf. Accessed August 16, 2017. 
87.  DIRECTORATE OF NATIONAL VECTOR BORNE DISEASE CONTROL, 
PROGRAMME (NVBDCP), DIRECTORATE GENERAL OF HEALTH 
SERVICES (DGHS), MINISTRY OF HEALTH & FAMILY WELFARE, 
GOVERNMENT OF INDIA. NATIONAL FRAMEWORK FOR MALARIA 
ELIMINATION IN INDIA.; 2016. 
http://www.searo.who.int/india/publications/national_framework_malaria_eliminat
ion_india_2016_2030.pdf?ua=1. Accessed December 29, 2017. 
88.  Tren R. Malaria and Climate Change in India.; 2002. 
 59 
http://www.libertyindia.org/pdfs/malaria_climatechange2002.pdf. Accessed 
August 16, 2017. 
89.  Arora D. Malaria in In India through the year. NMEP. 1980:3. 
90.  Director. NME. NME News. 1968:4. 
91.  Tyagi P, Roy A, Malhotra MS. Knowledge, awareness and practices towards malaria 
in communities of rural, semi-rural and bordering areas of east Delhi (India). J 
Vector Borne Dis. 2005;42(1):30-35. 
http://www.ncbi.nlm.nih.gov/pubmed/15999459. Accessed August 7, 2017. 
92.  Singh N, Singh MP, Saxena A, Sharma VP KN. No Title Knowledge, attitude, 
beliefs and practices (KABP) study related to malaria and intervention strategies in 
ethnic tribals of Mandla (Madhya Pradesh). Curr Sci. 1998;(75):1386-1390. 
93.  World Health Organization. World Malaria Report 2015.; 2015. 
http://www.who.int/malaria/publications/world-malaria-report-2015/wmr2015-
profiles.pdf. Accessed August 14, 2017. 
94.  Interactive Malaria Guide - Malaria Information. 
http://www.malariaconsortium.org/interactive-malaria-guide/malaria-
information/transmission. Accessed January 2, 2018. 
95.  Hammerich A, Campbell OMR, Chandramohan D. Unstable malaria transmission 
and maternal mortality - experiences from Rwanda. Trop Med Int Heal. 
2002;7(7):573-576. doi:10.1046/j.1365-3156.2002.00898.x. 
96.  Singh N, Chand SK, Mishra AK, et al. EPIDEMIOLOGY OF MALARIA IN AN 
AREA OF LOW TRANSMISSION IN CENTRAL INDIA. 
 60 
http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.504.5050&rep=rep1&ty
pe=pdf. Accessed January 2, 2018. 
97.  Druilhe P, Pérignon J-L. A hypothesis about the chronicity of malaria infection. 
Parasitol Today. 1997;13(9):353-357. doi:10.1016/S0169-4758(97)01095-8. 
98.  OSIER FHA, POLLEY SD, MWANGI T, LOWE B, CONWAY DJ, MARSH K. 
Naturally acquired antibodies to polymorphic and conserved epitopes of 
Plasmodium falciparum merozoite surface protein 3. Parasite Immunol. 
2007;29(8):387-394. doi:10.1111/j.1365-3024.2007.00951.x. 
99.  Wylie BJ, Hashmi AH, Singh N, et al. Availability and utilization of malaria 
prevention strategies in pregnancy in eastern India. BMC Public Health. 
2010;10(1):557. doi:10.1186/1471-2458-10-557. 
100.  Lindsay S, Ansell J, Selman C, Cox V, Hamilton K, Walraven G. Effect of 
pregnancy on exposure to malaria mosquitoes. Lancet. 2000;355(9219):1972. 
doi:10.1016/S0140-6736(00)02334-5. 
101.  Dobson R. Mosquitoes prefer pregnant women. BMJ. 2000;320(7249):1558B. 
http://www.ncbi.nlm.nih.gov/pubmed/10845953. Accessed August 21, 2017. 
102.  Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J 
Reprod Immunol. 2010;63(6):425-433. doi:10.1111/j.1600-0897.2010.00836.x. 
103.  Okoko BJ, Enwere G, Ota MOC. The epidemiology and consequences of maternal 
malaria: a review of immunological basis. Acta Trop. 2003;87(2):193-205. 
http://www.ncbi.nlm.nih.gov/pubmed/12826295. Accessed January 2, 2018. 
104.  Desai M, ter Kuile FO, Nosten F, et al. Epidemiology and burden of malaria in 
 61 
pregnancy. Lancet Infect Dis. 2007;7(2):93-104. doi:10.1016/S1473-
3099(07)70021-X. 
105.  Fleming AF. Tropical obstetrics and gynaecology. 1. Anaemia in pregnancy in 
tropical Africa. Trans R Soc Trop Med Hyg. 83(4):441-448. 
http://www.ncbi.nlm.nih.gov/pubmed/2694476. Accessed January 3, 2018. 
106.  Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A 
in the human placenta. Science. 1996;272(5267):1502-1504. 
http://www.ncbi.nlm.nih.gov/pubmed/8633247. Accessed July 27, 2017. 
107.  Duffy MF, Maier AG, Byrne TJ, et al. VAR2CSA is the principal ligand for 
chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. Mol 
Biochem Parasitol. 2006;148:117-124. doi:10.1016/j.molbiopara.2006.03.006. 
108.  Bardají A, Sigauque B, Sanz S, et al. Impact of Malaria at the End of Pregnancy on 
Infant Mortality and Morbidity. J Infect Dis. 2011;203(5):691-699. 
doi:10.1093/infdis/jiq049. 
109.  Abrams ET, Brown H, Chensue SW, et al. Host response to malaria during 
pregnancy: placental monocyte recruitment is associated with elevated beta 
chemokine expression. J Immunol. 2003;170(5):2759-2764. 
http://www.ncbi.nlm.nih.gov/pubmed/12594307. Accessed January 4, 2018. 
110.  Penha-Gonçalves C, Gozzelino R, de Moraes L V. Iron overload in Plasmodium 
berghei-infected placenta as a pathogenesis mechanism of fetal death. Front 
Pharmacol. 2014;5:155. doi:10.3389/fphar.2014.00155. 
111.  Schantz-Dunn J, Nour NM. Malaria and pregnancy: a global health perspective. Rev 
 62 
Obstet Gynecol. 2009;2(3):186-192. 
http://www.ncbi.nlm.nih.gov/pubmed/19826576. Accessed July 26, 2017. 
112.  Nosten F, McGready R, Simpson JA, et al. Effects of Plasmodium vivax malaria in 
pregnancy. Lancet (London, England). 1999;354(9178):546-549. 
http://www.ncbi.nlm.nih.gov/pubmed/10470698. Accessed July 24, 2017. 
113.  Kochar DK, Thanvi I, Joshi A, Subhakaran, Aseri S, Kumawat BL. Falciparum 
malaria and pregnancy. Indian J Malariol. 1998;35(3):123-130. 
http://www.ncbi.nlm.nih.gov/pubmed/10497838. Accessed July 26, 2017. 
114.  Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO. Quantifying the 
Number of Pregnancies at Risk of Malaria in 2007: A Demographic Study. Fisk 
NM, ed. PLoS Med. 2010;7(1):e1000221. doi:10.1371/journal.pmed.1000221. 
115.  Romday R, Gupta AK, Chilloria P, Sharma S, Bhambani P. Malaria and anaemia in 
pregnant and non-pregnant women of child-bearing age: a cross-sectional study. Int 
J Adv Med. 2017;4(2):344-349. 
http://www.ijmedicine.com/index.php/ijam/article/view/347/486. Accessed August 
21, 2017. 
116.  Datta M, Biswas J, Dasgupta S, et al. Comparative Study on Antenatal and Perinatal 
Outcome of Vivax and Falciparum Malaria in a Tertiary Care Hospital of Kolkata, 
India. J Clin Diagn Res. 2017;11(1):QC01-QC04. 
doi:10.7860/JCDR/2017/23051.9195. 
117.  Moore KA, Simpson JA, Wiladphaingern J, et al. Influence of the number and 
timing of malaria episodes during pregnancy on prematurity and small-for-
 63 
gestational-age in an area of low transmission. BMC Med. 2017;15(1):117. 
doi:10.1186/s12916-017-0877-6. 
118.  Ahmed R, Singh N, ter Kuile FO, et al. Placental infections with histologically 
confirmed Plasmodium falciparum are associated with adverse birth outcomes in 
India: a cross-sectional study. Malar J. 2014;13(1):232. doi:10.1186/1475-2875-13-
232. 
119.  Sohail M, Shakeel S, Kumari S, et al. Prevalence of Malaria Infection and Risk 
Factors Associated with Anaemia among Pregnant Women in Semiurban 
Community of Hazaribag, Jharkhand, India. Biomed Res Int. 2015;2015:1-16. 
doi:10.1155/2015/740512. 
120.  World Health Organization. Malaria Prevention Works - Let’s Close the Gap. 
www.who.int/malaria. Accessed July 27, 2017. 
121.  O’Meara WP, Mangeni JN, Steketee R, Greenwood B. Changes in the burden of 
malaria in sub-Saharan Africa. Lancet Infect Dis. 2010;10(8):545-555. 
doi:10.1016/S1473-3099(10)70096-7. 
122.  WHO | MDG 6: combat HIV/AIDS, malaria and other diseases. WHO. 
http://www.who.int/topics/millennium_development_goals/diseases/en/. Published 
2014. Accessed January 4, 2018. 
123.  ter Kuile FO, Terlouw DJ, Phillips-Howard PA, et al. Reduction of malaria during 
pregnancy by permethrin-treated bed nets in an area of intense perennial malaria 
transmission in western Kenya. Am J Trop Med Hyg. 2003;68(4 Suppl):50-60. 
http://www.ncbi.nlm.nih.gov/pubmed/12749486. Accessed August 17, 2017. 
 64 
124.  Phillips-Howard PA, Nahlen BL, Kolczak MS, et al. Efficacy of permethrin-treated 
bed nets in the prevention of mortality in young children in an area of high perennial 
malaria transmission in western Kenya. Am J Trop Med Hyg. 2003;68(4 Suppl):23-
29. http://www.ncbi.nlm.nih.gov/pubmed/12749482. Accessed August 17, 2017. 
125.  Stewart T, Marchand RP. Factors That Affect the Success and Failure of 
InsecticideTreated Net Programs for Malaria Control in SE Asia and the Western 
Pacific. http://www.who.int/malaria/publications/atoz/itn_r62.pdf. Accessed July 
27, 2017. 
126.  Jambulingam P, Gunasekaran K, Sahu S, Vijayakumar T. Insecticide treated 
mosquito nets for malaria control in India-experience from a tribal area on 
operational feasibility and uptake. Mem Inst Oswaldo Cruz. 2008;103(2):165-171. 
http://www.ncbi.nlm.nih.gov/pubmed/18392548. Accessed July 27, 2017. 
127.  Menéndez C, Bardají A, Sigauque B, et al. A Randomized Placebo-Controlled Trial 
of Intermittent Preventive Treatment in Pregnant Women in the Context of 
Insecticide Treated Nets Delivered through the Antenatal Clinic. Meshnick SR, ed. 
PLoS One. 2008;3(4):e1934. doi:10.1371/journal.pone.0001934. 
128.  Asa OO, Onayade AA, Fatusi AO, Ijadunola KT, Abiona TC. Efficacy of 
intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine in 
preventing anaemia in pregnancy among Nigerian women. Matern Child Health J. 
2008;12(6):692-698. doi:10.1007/s10995-008-0319-3. 
129.  Challis K, Osman NB, Cotiro M, Nordahl G, Dgedge M, Bergström S. Impact of a 
double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy 
 65 
malaria in southern Mozambique. Trop Med Int Health. 2004;9(10):1066-1073. 
doi:10.1111/j.1365-3156.2004.01307.x. 
130.  Diakite O, Kayentao K, Traore BT, et al. Superiority of 3 Over 2 Doses of 
Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine for the 
Prevention of Malaria During Pregnancy in Mali: A Randomized Controlled Trial. 
Clin Infect Dis. 2011;53(3):215-223. doi:10.1093/cid/cir374. 
131.  Tukur IU, Thacher TD, Sagay AS, Madaki JKA. A comparison of sulfadoxine-
pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in 
pregnant Nigerian women. Am J Trop Med Hyg. 2007;76(6):1019-1023. 
http://www.ncbi.nlm.nih.gov/pubmed/17556604. Accessed August 17, 2017. 
132.  Tarning J. Treatment of Malaria in Pregnancy. N Engl J Med. 2016;374(10):981-
982. doi:10.1056/NEJMe1601193. 
133.  Government of India; National Institute of Malaria Research; National Vector Borne 
Disease Control Programme. Guidelines for Diagnosis and Treatment of Malaria in 
India 2009 Guidelines for Diagnosis and Treatment of Malaria in India.; 2009. 
http://nvbdcp.gov.in/Doc/Guidelines_for_Diagnosis___Treatment.pdf. Accessed 
January 4, 2018. 
134.  Chapman RR. Endangering safe motherhood in Mozambique: prenatal care as 
pregnancy risk. Soc Sci Med. 2003;57(2):355-374. 
http://www.ncbi.nlm.nih.gov/pubmed/12765714. Accessed July 28, 2017. 
135.  Ahorlu CK, Koram KA, Weiss MG. Children, Pregnant Women and the Culture of 
Malaria in Two Rural Communities of Ghana. Anthropol Med. 2007;14(2):167-181. 
 66 
doi:10.1080/13648470701381473. 
136.  Agyepong IA, Wellington EK, Abbey MA. A comparative study of clinical and 
sociocultural aspects of anaemia among adolescent girls in rural Ghana. Acta Trop. 
1997;65(3):123-138. http://www.ncbi.nlm.nih.gov/pubmed/9177574. Accessed 
July 28, 2017. 
137.  Sahoo SK, Taraphdar P, Mallick AK, Dasgupta A, Preeti PS, Biswas D. How aware 
are we regarding vector borne diseases? A community based study in a slum of 
Kolkata, India. Int J Res Med Sci. 2017;5(6):2629. doi:10.18203/2320-
6012.ijrms20172460. 
138.  WHO recommendations on antenatal care for a positive pregnancy experience WHO 
Library Cataloguing-in-Publication Data WHO recommendations on antenatal care 
for a positive pregnancy experience. IWorld Heal Organ from World Heal Organ. 
http://www.who.int. Accessed January 4, 2018. 
139.  Implementing Malaria in Pregnancy Programs in the Context of World Health 
Organization Recommendations on Antenatal Care for a Positive Pregnancy 
Experience.; 2017. www.mcsprogram.org. Accessed January 4, 2018. 
140.  Simkhada B, Teijlingen ER van, Porter M, Simkhada P. Factors affecting the 
utilization of antenatal care in developing countries: systematic review of the 
literature. J Adv Nurs. 2008;61(3):244-260. doi:10.1111/j.1365-2648.2007.04532.x. 
141.  Mathole T, Lindmark G, Majoko F, Ahlberg BM. A qualitative study of women’s 
perspectives of antenatal care in a rural area of Zimbabwe. Midwifery. 
2004;20(2):122-132. doi:10.1016/j.midw.2003.10.003. 
 67 
142.  Vijayakumar KN, Gunasekaran K, Sahu SS, Jambulingam P. Knowledge, attitude 
and practice on malaria: A study in a tribal belt of Orissa state, India with reference 
to use of long lasting treated mosquito nets. Acta Trop. 2009;112(2):137-142. 
doi:10.1016/j.actatropica.2009.07.011. 
143.  Das A, Ravindran TS. Factors affecting treatment-seeking for febrile illness in a 
malaria endemic block in Boudh district, Orissa, India: policy implications for 
malaria control. Malar J. 2010;9(1):377. doi:10.1186/1475-2875-9-377. 
144.  Das A, Gupta R Das, Friedman J, Pradhan MM, Mohapatra CC, Sandhibigraha D. 
Community perceptions on malaria and care-seeking practices in endemic Indian 
settings: policy implications for the malaria control programme. Malar J. 
2013;12(1):39. doi:10.1186/1475-2875-12-39. 
145.  Sundararajan R, Kalkonde Y, Gokhale C, Greenough PG, Bang A. Barriers to 
Malaria Control among Marginalized Tribal Communities: A Qualitative Study. 
Gosling RD, ed. PLoS One. 2013;8(12):e81966. doi:10.1371/journal.pone.0081966. 
146.  Mazumdar S. Prevalence, risk factors and treatment-seeking behaviour for malaria: 
the results of a case study from the Terai region of West Bengal, India. Ann Trop 
Med Parasitol. 2011;105(3):197-208. doi:10.1179/136485911X12987676649548. 
147.  Bhattacharyya H. Knowledge, beliefs, and practices regarding malaria in urban 
setting of East Khasi Hills district, Meghalaya. Int J Med Sci Public Heal Int J Med 
Sci Public Heal Online. 2015;4:1042-1045. 
doi:10.5455/ijmsph.2015.16092014214. 
148.  Joseph N, Nelliyanil M, Kotian SM, et al. Awareness, practices and expenditure 
 68 
towards mosquito bite prevention methods in urban and semi-urban areas of South 
India. Int J Mosq Res IJMR. 2015;53(21):53-59. 
http://www.dipterajournal.com/vol2issue1/pdf/2-2-16.1.pdf. Accessed July 30, 
2017. 
149.  Lwin MO, Vijaykumar S, Lim G, Theng Y-L, Foo S. Personal protection behaviors 
against Malaria in India : urban attitudes and health info seeking preferences. 2013. 
https://dr.ntu.edu.sg/handle/10220/24298. Accessed July 29, 2017. 
150.  Imtiaz F, Nisar N, Shafi K, Nawab F. Knowledge and Practices Regarding Malaria 
Control and its Treatment among Patients Visiting Outpatient Clinics of Civil 
Hospital Khairpur. (ASH KMDC. 2015;21(4):221-227. http://www.annals-
ashkmdc.org/pdfs/2016/4/5.pdf. Accessed July 30, 2017. 
151.  Sood RD, Mittal PK, Kapoor N, Razdan RK, Dua VK, Dash AP. Community 
awareness, perceptions, acceptability and preferences for using LLIN against 
malaria in villages of Uttar Pradesh, India. J Vector Borne Dis. 2010;47:243-248. 
https://search.proquest.com/openview/cb6cefe46c1788db9d5ec88f3cda9c28/1?pq-
origsite=gscholar&cbl=54552. Accessed July 29, 2017. 
152.  Vala MC, Patel U V, Joshi NB, Zalavadiya DD, Viramgami AP, Sharma S. 
Knowledge and practice regarding malaria Knowledge and practice regarding 
malaria among people of urban and rural areas of Rajkot District, Gujarat, India. Int 
J Res Med. 2013;2(4):38-42. 
http://www.ijorim.com/siteadmin/article_issue/138989844710_Mayur Vala.pdf. 
Accessed July 30, 2017. 
 69 
153.  van Eijk AM, Ramanathapuram L, Sutton PL, et al. The use of mosquito repellents 
at three sites in India with declining malaria transmission: surveys in the community 
and clinic. Parasit Vectors. 2016;9(1):418. doi:10.1186/s13071-016-1709-9. 
154.  Mishra RN, Singh SP, Vanlerberghe V, Sundar S, Boelaert M, Lefèvre P. Lay 
perceptions of kala-azar, mosquitoes and bed nets in Bihar, India. Trop Med Int 
Heal. 2010;15(s2):36-41. doi:10.1111/j.1365-3156.2010.02544.x. 
155.  Lwin MO, Vijaykumar S, Lim G, Theng YL, Foo S. “It”s effective but should I 
bother?’ A study of personal protection measures against Malaria in urban India. 
Public Health. 2014;128(7):654-664. doi:10.1016/j.puhe.2014.03.008. 
156.  Gupta RK, Raina SK, Shora TN, Jan R, Sharma R, Hussain S. A household survey 
to assess community knowledge, attitude and practices on malaria in a rural 
population of Northern India. J Fam Med Prim care. 2016;5(1):101-107. 
doi:10.4103/2249-4863.184632. 
157.  Ghosh A, Sarkar D, Pal R, Mukherjee B. Burden of Malaria and Health Service 
Utilization in a Tribal Community of West Bengal State, India. Am J Public Heal 
Res Vol 3, 2015, Pages 182-185. 2015;3(5A):182-185. doi:10.12691/AJPHR-3-5A-
38. 
158.  Yadav SP, Kalundha RK, Sharma RC. Sociocultural factors and malaria in the desert 
part of Rajasthan, India. J Vect Borne Dis. 2007;44:205-212. 
http://www.mrcindia.org/journal/issues/443205.pdf?origin=publication. Accessed 
July 30, 2017. 
159.  Hill J, D’Mello-Guyett L, Hoyt J, van Eijk AM, ter Kuile FO, Webster J. Women’s 
 70 
Access and Provider Practices for the Case Management of Malaria during 
Pregnancy: A Systematic Review and Meta-Analysis. Menéndez C, ed. PLoS Med. 
2014;11(8):e1001688. doi:10.1371/journal.pmed.1001688. 
160.  Milman N, Byg KE, Agger AO. Hemoglobin and erythrocyte indices during normal 
pregnancy and postpartum in 206 women with and without iron supplementation. 
Acta Obstet Gynecol Scand. 2000;79(2):89-98. 
http://www.ncbi.nlm.nih.gov/pubmed/10696955. Accessed January 4, 2018. 
161.  Brabin BJ. The Role of Malaria in Nutritional Anemias. Nutr Anemias Nestle Nutr 
Work Ser. 30. 
https://pdfs.semanticscholar.org/981c/7036670839a3e7292c877ea52ff65de50ae8.p
df. Accessed January 4, 2018. 
162.  Gilles HM, Lawson JB, Sibelas M, Voller A, Allan N. Malaria, anaemia and 
pregnancy. Ann Trop Med Parasitol. 1969;63(2):245-263. 
http://www.ncbi.nlm.nih.gov/pubmed/4190223. Accessed January 4, 2018. 
163.  Sabin LL, Rizal A, Brooks MI, et al. Attitudes, knowledge, and practices regarding 
malaria prevention and treatment among pregnant women in eastern India. Am J 
Trop Med Hyg. 2010;82(6):1010-1016. doi:10.4269/ajtmh.2010.09-0339. 
164.  Sabin, Lora; Brooks, Mohamad I; Rizal, Abanish; Singh, Mrigendra P; Wylie, Blair 
J; Hecht, Evan M.S; Banos, Matthew; Bondzie, Philip A; Tuchman, Jordan; 
Yeboah-Antwi, Kojo; Singh, Neeru; Hamer DH. Merging Modern Approaches with 
Tradition: A Qualitative Study of Attitudes, Knowledge, and Behaviors Related to 
Malaria Prevention and Treatment among Pregnant Women in India. Unpubl 
 71 
Manuscr. 2017. 
165.  World Health Organization. Advocacy, Communication and Social Mobilization for 
TB Control.; 2008. 
http://apps.who.int/iris/bitstream/10665/43790/1/9789241596176_eng.pdf. 
Accessed August 16, 2017. 
166.  Olalekan AW, Adebukola AM. Effects of Training on Knowledge, Attitude and 
Practices of Malaria Prevention and Control among Community Role Model Care 
Givers in South Western Nigeria. Ethiop J Health Sci. 2015;25(4):329-336. 
http://www.ncbi.nlm.nih.gov/pubmed/26949297. Accessed August 16, 2017. 
167.  Sundararajan R, Kalkonde Y, Gokhale C, Greenough PG, Bang A. Barriers to 
Malaria Control among Marginalized Tribal Communities: A Qualitative Study. 
Gosling RD, ed. PLoS One. 2013;8(12):e81966. doi:10.1371/journal.pone.0081966. 
168.  Mansi Motwani. Mobile clinics accessible to people from Chhattisgarh’s Red 
Corridor. https://www.newsbytesapp.com/timeline/India/3786/22509/health-
facilities-in-the-red-corridor. Published 2016. Accessed August 20, 2017. 
169.  Medecins Sans Frontiers. India: “Helping these people so far away from the real 
world is what pulls me out from the bed every morning!” | Médecins Sans Frontières 
(MSF) International. http://www.msf.org/en/article/india-“helping-these-people-so-
far-away-real-world-what-pulls-me-out-bed-every-morning.” Published 2015. 
Accessed August 20, 2017. 
170.  Guest G, Bunce A, Johnson L. How Many Interviews Are Enough? Field methods. 
2006;18(1):59-82. doi:10.1177/1525822X05279903. 
 72 
171.  Borooah VK. Deprivation, Violence, and Conflict: An Analysis of Naxalite Activity 
in the Districts of India. Int J Confl Violence. 2008;2(2):317-333. 
doi:10.4119/UNIBI/IJCV.42. 
172.  Berg BL. Qualitative Research Methods for the Social Sciences. 5th ed. New York: 
Pearson Education; 2004. http://www.msu.ac.zw/elearning/material/1344156815 
Reading 4 qualitative research methods for social sciences.pdf. Accessed August 23, 
2017. 
173.  Uddenfeldt Wort U, Hastings I, Bergström S, Massawe S, Lipingu C, Brabin BJ. 
Increased postpartum blood loss in pregnancies associated with placental malaria. 
Int J Gynecol Obstet. 2007;96(3):171-175. doi:10.1016/j.ijgo.2006.11.023. 
174.  Wylie BJ, Hashmi AH, Singh N, et al. Availability and utilization of malaria 
prevention strategies in pregnancy in eastern India. BMC Public Health. 
2010;10:557. doi:10.1186/1471-2458-10-557. 
  
 73 
CURRICULUM VITAE 
 74 
 75 
